<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.1 20151215//EN" "JATS-journalpublishing1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
         xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         dtd-version="1.1"
         xml:lang="sl"
         article-type="other">
   <front>
      <journal-meta>
         <journal-id journal-id-type="publisher-id">Zdrav Vestn</journal-id>
         <journal-id journal-id-type="nlm-ta">Zdrav Vestn</journal-id>
         <journal-id journal-id-type="doi">Zdrav Vestn</journal-id>
         <journal-title-group>
            <journal-title>Zdravniški vestnik</journal-title>
            <trans-title-group xml:lang="en">
               <trans-title>Slovenian Medical Journal</trans-title>
            </trans-title-group>
            <abbrev-journal-title>Zdrav Vestn</abbrev-journal-title>
         </journal-title-group>
         <issn publication-format="ppub" pub-type="ppub">1318-0347</issn>
         <issn publication-format="epub" pub-type="epub">1581-0224</issn>
         <issn-l>0350-0063</issn-l>
         <publisher>
            <publisher-name xml:lang="sl">Slovensko zdravniško društvo</publisher-name>
            <publisher-name xml:lang="en">Slovenian Medical Association</publisher-name>
            <publisher-loc xml:lang="sl">Ljubljana, Slovenia</publisher-loc>
         </publisher>
      </journal-meta>
      <article-meta>
         <article-id pub-id-type="doi">10.6016/ZdravVestn.2485</article-id>
         <article-id pub-id-type="publisher-id">2485</article-id>
         <article-categories>
            <subj-group subj-group-type="discipline" xml:lang="en">
               <subject>Medicine and health sciences</subject>
               <subj-group>
                  <subject>Public health (occupational medicine)</subject>
               </subj-group>
            </subj-group>
            <subj-group subj-group-type="discipline" xml:lang="sl">
               <subject>Medicina/Zdravstvo</subject>
               <subj-group>
                  <subject>Javno zdravstvo (varstvo pri delu)</subject>
               </subj-group>
            </subj-group>
            <subj-group subj-group-type="article-type" xml:lang="en">
               <subject>Professional article</subject>
            </subj-group>
            <subj-group subj-group-type="article-type" xml:lang="sl">
               <subject>Strokovni članek</subject>
            </subj-group>
            <subj-group subj-group-type="heading" xml:lang="sl">
               <subject>Javno zdravstvo (varstvo pri delu)</subject>
            </subj-group>
         </article-categories>
         <title-group>
            <article-title xml:lang="sl">Pomen in pravni status priporočil in smernic</article-title>
            <trans-title-group>
               <trans-title xml:lang="en">The importance and legal status of the recommendations and guidelines</trans-title>
            </trans-title-group>
            <alt-title alt-title-type="running-head" xml:lang="sl">Pomen in pravni status priporočil in smernic</alt-title>
         </title-group>
         <contrib-group>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Popovič</surname>
                  <given-names>Bojan</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
               <xref ref-type="corresp" rid="corr"/>
            </contrib>
         </contrib-group>
         <aff-alternatives id="aff1">
            <aff xml:lang="sl">
               <label>1</label>
               <institution>Dermadent d.o.o., Ljubljana, Slovenija</institution>
            </aff>
            <aff xml:lang="en">
               <label>1</label>
               <institution>Dermadent d.o.o., Ljubljana, Slovenia</institution>
            </aff>
         </aff-alternatives>
         <author-notes>
            <fn fn-type="conflict" xml:lang="en">
               <p>The authors have declared that no competing interests exist.</p>
            </fn>
            <fn fn-type="conflict" xml:lang="sl">
               <p>Avtorji so izjavili, da ne obstajajo nobeni konkurenčni interesi.</p>
            </fn>
            <corresp id="corr">Bojan Popovič, e-mail: <email xlink:type="simple"/>
            </corresp>
         </author-notes>
         <pub-date pub-type="ppub">
            <month>8</month>
            <year>2018</year>
         </pub-date>
         <pub-date pub-type="epub">
            <month>8</month>
            <year>2018</year>
         </pub-date>
         <volume>87</volume>
         <issue>7–8</issue>
         <fpage>365</fpage>
         <lpage>77</lpage>
         <history>
            <date date-type="received">
               <day>1</day>
               <month>2</month>
               <year>2017</year>
            </date>
            <date date-type="accepted">
               <day>13</day>
               <month>7</month>
               <year>2018</year>
            </date>
         </history>
         <permissions>
            <copyright-statement xml:lang="en">Copyright © 2018, Slovenian Medical Association (SZD)</copyright-statement>
            <copyright-statement xml:lang="sl">© 2018, Slovensko zdravniško društvo (SZD)</copyright-statement>
            <copyright-year>2018</copyright-year>
            <copyright-holder xml:lang="en">Slovenian Medical Association (SZD)</copyright-holder>
            <copyright-holder xml:lang="sl">Slovensko zdravniško društvo (SZD)</copyright-holder>
            <license xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                     xlink:type="simple"
                     xml:lang="en">
               <license-p>This is an open access article distributed under the terms of the
          <ext-link ext-link-type="uri"
                            xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                            xlink:type="simple">Creative Commons Attribution-NonCommercial
            License</ext-link>, which permits unrestricted use, distribution, and
          reproduction in any medium, provided the original author and source are
          credited and only for non-commercial purposes. </license-p>
            </license>
            <license xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                     xlink:type="simple"
                     xml:lang="sl">
               <license-p>To je članek z odprtim dostopom, ki ga lahko uporabite pod pogoji iz
          <ext-link ext-link-type="uri"
                            xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                            xlink:type="simple">Creative Commons Priznanje avtorstva-Nekomercialno
            licence</ext-link>. ki dovoljuje distribucijo, predelavo ali
          prilagoditev, ter gradijo na njem, v nekomercialne namene, z navedbo avtorja
          in izvirnega dela.</license-p>
            </license>
         </permissions>
         <abstract xml:lang="sl">
            <title>Izvleček</title>
            <p>Smernice so znanstveni prispevek, ki temelji na konsenzualnih priporočilih stroke z visoko kakovostjo dokazov in odgovarjajo na praktična vprašanja odločevalcev, zlasti pa financerjev in izvajalcev zdravstvenih storitev. Pravno sicer niso obvezujoče, vendar si jih zaradi pravnega načela dolžne skrbnosti tako izvajalci kot financerji težko privoščijo ignorirati. Avtorji smernic morajo razkriti vse okoliščine, ki predstavljajo konflikt interesov ali ustvarjajo videz tega konflikta. Tuje smernice imajo v slovenskem prostoru značaj poglobljenega znanstvenega prispevka ali priporočila in se ne morejo neposredno uporabljati kot slovenske smernice, če pred tem niso bile pregledane tudi slovenske študije na temo, ki jih tuje smernice pokrivajo. Priporočila in klinične smernice v Sloveniji oblikujejo strokovna združenja, potrjujejo pa jih strokovni sveti za posamezno stroko in nato še Glavni strokovni svet pri Slovenskem zdravniškem društvu. Za sprejem nacionalnih smernic je trenutno v Sloveniji pristojen zdravstveni svet, bolje pa bi bilo, če bi to nalogo opravljala neodvisna agencija.</p>
         </abstract>
         <trans-abstract xml:lang="en">
            <title>Abstract</title>
            <p>Guidelines are a scientific contribution based on the consensual recommendations with a high quality and level of evidence aimed at giving high quality answers to decision makers, especially health care providers and payors. Guidelines are not legally binding, but because of the legal principle of due diligence they are difficult to ignore when decisions are made. Authors of guidelines must disclose any actual or potential conflict of interest. Foreign guidelines are considered as recommendations in Slovenia and cannot be directly used as Slovenian guidelines until Slovenian studies are considered. In Slovenia, the recommendations and clinical guidelines are prepared by professional medical associations and approved by professional committees and the Main Professional Committee established by the Slovenian Medical Association. Currently, the Health Council at the Ministry of Health is responsible to approve the national guidelines, but an independent agency would be more appropriate.</p>
         </trans-abstract>
         <kwd-group xml:lang="sl">
            <kwd>klinično stališče</kwd>
            <kwd>priporočilo</kwd>
            <kwd>klinične smernice</kwd>
            <kwd>nacionalne smernice</kwd>
            <kwd>standard</kwd>
            <kwd>klinična pot</kwd>
            <kwd>dolžna skrbnost</kwd>
            <kwd>malomarnost</kwd>
            <kwd>univerzalno zdravstveno varstvo</kwd>
            <kwd>zdravstveni svet</kwd>
            <kwd>razširjeni strokovni kolegij</kwd>
            <kwd>strokovni svet</kwd>
            <kwd>konflikt interesov</kwd>
         </kwd-group>
         <kwd-group xml:lang="en">
            <kwd>position statement</kwd>
            <kwd>recommendation</kwd>
            <kwd>clinical guideline</kwd>
            <kwd>national guideline</kwd>
            <kwd>standard</kwd>
            <kwd>clinical path</kwd>
            <kwd>due care</kwd>
            <kwd>negligence</kwd>
            <kwd>universal healthcare</kwd>
            <kwd>Health Council</kwd>
            <kwd>extended professional committee</kwd>
            <kwd>professional council</kwd>
            <kwd>conflict of interests</kwd>
         </kwd-group>
      </article-meta>
   </front>
   <body>
      <sec id="s1" sec-type="Od raziskav do priporočil">
         <label>1</label>
         <title>Od raziskav do priporočil</title>
         <p>Medicina je znanstvena veda, ki temelji na znanstvenih spoznanjih. V znanosti ne obstaja neka formalna vrhovna avtoriteta, ki bi sprejemala zakone, ki bi bili potem obvezujoči za vse. Izhodišče znanstvenega raziskovanja je hipoteza, trditev, ki jo raziskovalec postavi in jo v procesu raziskovanja poskusi potrditi ali ovreči. Potrjena hipoteza postane teorija, lahko tudi stališče avtorjev, torej ena od možnih razlag raziskovanega pojava. Teorije nato postanejo predmet znanstvene razprave, v kateri jih različni raziskovalci testirajo v različnih pogojih in v različnih populacijah, dokler v okviru raznih strokovnih združenj ne pridejo do določenega konsenza. Stališča, ki predstavljajo mnenje uradnih predstavnikov strokovnih medicinskih združenj ali zdravniških stanovskih organizacij, ki pa še niso v celoti pripravljena po standardnih uveljavljenih merilih sistematičnega pregleda in vrednotenja dokazov, se imenujejo klinična stališča (<italic toggle="yes">angl.</italic>
            <italic toggle="yes"> </italic>position statements) (povzeto po Predlogu poti sprejemanja strokovnih priporočil, kliničnih smernic in nacionalnih smernic, Slovensko zdravniško društvo, dopis Zdravstvenemu svetu, št. 18–18/1 z dne 30. 1. 2018, v nadaljevanju Predlog SZD).</p>
         <p>Da bi verodostojnost stališč še dodatno objektivizirali, so se razvili formalni in standardizirani sistemi sprejemanja, ki jih prav tako izvajajo strokovna zdravniška združenja, v katerih je treba poleg ugotovitev znanstvenoraziskovalnega dela upoštevati tudi že obstoječe klinične smernice in mednarodne smernice, kar v praksi pomeni, da za njimi stoji bistveno večje število raziskav, opravljenih praviloma na mednarodni ravni, na bistveno večji populaciji in v širšem geografskem prostoru, skozi daljši čas ter imajo zato višjo stopnjo verodostojnosti kot stališča. Tako oblikovana besedila se po Predlogu SZD imenujejo strokovna priporočila (<italic toggle="yes">angl.</italic>
            <italic toggle="yes"> </italic>recommendations). Tudi strokovna priporočila pa še ne vsebujejo sistematičnega pregleda mednarodne in domače strokovne literature z dokumentiranim vrednotenjem dokazov, zaradi česar niso vsa priporočila enako verodostojna. U.S. Preventive Services Task Force (USPSTF) kakovost priporočil rangira s črkami A, B, C, D, I, ki odsevajo neto učinek (torej razmerje med koristmi in škodo) uvedbe določenega priporočila v prakso, pri čemer se opira na število in velikost študij, na katerih priporočilo temelji (<xref ref-type="bibr" rid="b1">1</xref>). Podobna sta Oxfordski CEBM Levels of Evidence (<xref ref-type="bibr" rid="b2">2</xref>), in sistem GRADE (Grading of Recommendations Assessment, Development and Evaluation) (<xref ref-type="bibr" rid="b3">3</xref>), ki stališča klasificirata glede na kakovost dokazov.</p>
      </sec>
      <sec id="s2" sec-type="Struktura priporočil">
         <label>2</label>
         <title>Struktura priporočil</title>
         <p>Priporočilo je konsenz večjega števila strokovnjakov, delujočih v okviru določenega strokovnega združenja, glede enostavne in jasne povédi, sestavljene iz dveh stavkov, ki sta med seboj povezana z besedo »naj« ali »naj ne«. Prvi stavek opisuje situacijo, drugi pa želeno (»naj«) ali neželeno (»naj ne«) ravnanje v takšni situaciji. Primer: »Kliniki naj ne izvajajo testov oziroma naj ne začenjajo zdravljenja z antibiotiki pri bolnikih z bronhitisom, razen če obstaja sum na pljučnico« (<xref ref-type="bibr" rid="b4">4</xref>).</p>
         <p>Temu nato sledi argumentacija, v kateri avtorji priporočil v uvodnem delu pojasnijo motive za njihov sprejem in glavne epidemiološke kazalce. Sledi opis standardizirane metodologije, v kateri so navedene baze podatkov, iz katerih so avtorji črpali podatke oziroma dokaze. Obvezen je seveda tudi seznam uporabljene literature in virov, med katerimi morajo biti tudi že obstoječe klinične smernice in mednarodne smernice.</p>
         <p>Pomemben sestavni del priporočil je klavzula o odgovornosti. Avtorji v priporočilih po navadi izključijo svojo odgovornost za kakršno koli škodo, ki bi nastala zaradi uporabe priporočil. To je tudi logično, saj gre za neobvezujoč dokument, ko praktik presodi njihovo uporabljivost in smiselnost v konkretnem primeru.</p>
      </sec>
      <sec id="s3" sec-type="Od priporočil do smernic">
         <label>3</label>
         <title>Od priporočil do smernic</title>
         <p>Smernice (<italic toggle="yes">angl.</italic>
            <italic toggle="yes"> </italic>guidelines) so priporočila, ki so temelj za oblikovanje določene strategije ali politike. Od priporočil se razlikujejo predvsem v tem, da priporočila nimajo konkretnega naslovnika in sama po sebi ne povzročajo praktičnih učinkov, medtem ko so smernice tista priporočila, ki jih odločevalec ali izvajalec uporabi pri načrtovanju ali izvedbi svojih aktivnosti, strategij ali odločitev (<xref ref-type="bibr" rid="b5">5</xref>). Svetovna zdravstvena organizacija izrecno navaja, da je priporočila, ki vplivajo na izvajanje javnih politik ali na klinično prakso, treba šteti kot smernice (<xref ref-type="bibr" rid="b6">6</xref>). Razlogi, zaradi katerih bi nek odločevalec potreboval smernice, so različni. Najpogostejša razloga pa sta dva:</p>
         <list>
            <list-item>
               <label>•</label>
               <p>obvladovanje pravnih tveganj, torej neugodnega izida pravnih postopkov, v katerih se naročnik smernic potencialno lahko znajde;</p>
            </list-item>
            <list-item>
               <label>•</label>
               <p>odločanje o financiranju programov.</p>
            </list-item>
         </list>
         <p>Ker so smernice dokument, ki ima tako pravne kot ekonomske učinke, seveda ne moremo kar vsakega priporočila že šteti kot smernice.</p>
         <p>V prvem primeru odločevalec (po navadi izvajalec zdravstvene dejavnosti) želi vedeti, za katere postopke je utemeljeno mogoče pričakovati, da bo z njimi preprečil škodo kot temelj odškodninske odgovornosti. Zanimajo ga torej tista priporočila, ki so dovolj verodostojna, da bi morebitni oškodovanec lahko dokazal pomanjkljivo skrbnost, če jih izvajalec ne bi upošteval. Predlog SZD, ki ga je potrdil Zdravstveni svet, takšna priporočila poimenuje klinične smernice. Ta izraz priznava le tistim priporočilom, ki temeljijo na najvišji stopnji kakovosti dokazov, ki jih imamo v določenem trenutku na voljo, in pri pripravi katerih je zagotovljeno večdisciplinarno sodelovanje različnih strokovnjakov in drugih zainteresiranih predstavnikov, praviloma tudi predstavnikov organizacij bolnikov.</p>
         <p>Drugi primer pa je povezan z definicijo javnega zdravstva. Le-to je sistem, ki vsakomur, brez diskriminacije, omogoča dostop do potrebnih in strokovno upravičenih zdravstvenih storitev v razumnem času. Javni zdravstveni sistem torej mora na makro ravni vsakomur zagotoviti v bistvu točno to, kar mora zagotoviti posamezni izvajalec posamezniku na mikro ravni. Organizatorja javnega zdravstva zanima, katere zdravstvene storitve ali postopke mora uporabnikom zagotoviti, da ne bi kršil definicije javnega zdravstva. Predlog SZD takšna priporočila poimenuje nacionalne smernice. Vsebovati morajo tudi ekonomsko oceno virov (kadrov, opreme in prostorov), logistično ali organizacijsko izvedbo in obvladovanje tveganj.</p>
         <p>Med kliničnimi in nacionalnimi smernicami ne bi smelo biti pomembnejših razlik. V obeh primerih naročnika zanima čim boljša selekcija priporočil, ki si jih zaradi njihove strokovne prepričljivosti težko privošči ignorirati. V obeh primerih se hoče čim bolj razbremeniti priporočil, ki za doseganje ciljev niso pomembna ali niso dovolj prepričljiva.</p>
      </sec>
      <sec id="s4" sec-type="Pravni status priporočil in smernic">
         <label>4</label>
         <title>Pravni status priporočil in smernic</title>
         <p>Smernice same po sebi niso predpis, saj uporabnik storitve ne more od izvajalca iztožiti, naj mu storitev zagotovi po postopku, ki je v smernicah zapisan. Toda če so strokovno verodostojne, je ob dokazani kršitvi smernic precej verjetno, da bo bolnik po temelju dokazal svoj odškodninski zahtevek. Analogno je v primeru tožbe pred socialnim sodiščem v primeru kršitve smernic precej verjetno, da bo bolnik dokazal kršitev pravic iz javnega zdravstvenega zavarovanja oziroma oviranje dostopa do storitve, ki mu jo mora javni zdravstveni sistem omogočiti.</p>
         <p>Smernice niso algoritmi ali klinične poti in izvajalcu ne dajejo navodil, kako naj nek postopek izvaja. So strateški dokument, ki se opredeljuje do znanstvene dokazanosti različnih idej ali predlogov glede postopanja v definiranih okoliščinah. Izvajalec se potem sam odloča, katerega priporočenih postopkov ali katero kombinacijo bo izvajal. Smernice same po sebi teoretično nimajo odločilne vloge pri ugotavljanju, ali je zdravnik ravnal protipravno ali ne. Bolnik lahko sam preiskuje medicinsko literaturo in pri tem išče kateri koli dokaz (npr. študijo, raziskavo ipd.), iz katerega je mogoče dokazati, da bi v danem primeru neka druga metoda oz. drugačno ravnanje zdravnika pripeljala do drugačnega rezultata. V tem se smernice bistveno razlikujejo od normativnih aktov – slednji so veljavni, če jih sprejme zakonodajalec, ne glede na njihovo znanstveno oz. dejansko prepričljivost, medtem ko so smernice veljavne le toliko, kolikor ne obstaja drug prepričljivejši dokaz. Kljub temu pa igrajo lahko smernice pomembno vlogo pri ugotavljanju odškodninske odgovornosti pri vprašanjih dolžne skrbnosti (<xref ref-type="bibr" rid="b7">7</xref>). Eden ključnih elementov odškodninske odgovornosti je vzročna zveza, pri kateri se ugotavlja, ali je ravnanje ali opustitev ravnanja zdravnika povzročilo škodo, ki jo je utrpel bolnik. Prav smernice pa lahko na to vprašanje najbolj kakovostno odgovorijo, saj iz njih dokaj enostavno izluščimo, kateri postopki so bili za določene primere že predlagani in kakšna je njihova znanstvena prepričljivost. Postopki, za katere ni močnih in prepričljivih dokazov o učinkovitosti, ali postopki, za katere je celo dokazana neučinkovitost (oziroma nezadostno odstopanje od placeba), namreč niso v sferi dolžne skrbnosti zdravnika, saj ni mogoče dokazati, da je povzročila škodo njihova opustitev. In seveda obratno: če zdravnik izvaja takšen postopek, mora v primeru stranskih učinkov dokazati, da je bolnika o pričakovanih tveganjih in koristih prej seznanil in da je bolnik v to privolil.</p>
         <p>V nemški sodni praksi obstajajo številni primeri, v katerih so sodišča opredelila vlogo smernic na omenjeni način (<xref ref-type="bibr" rid="b8">8</xref>). Enak status jim pripisuje tudi Hurwitz (<xref ref-type="bibr" rid="b9">9</xref>).</p>
      </sec>
      <sec id="s5"
           sec-type="Ali so smernice vzvod za pridobivanje javnih sredstev?">
         <label>5</label>
         <title>Ali so smernice vzvod za pridobivanje javnih sredstev?</title>
         <p>Pravilno izdelane smernice ne bi smele biti neposreden vzvod za pridobivanje dodatnih javnih sredstev, saj izvajalcu pustijo dokajšnjo avtonomijo glede izbire priporočenih postopkov in tudi glede njihove logistične ali organizacijske izvedbe. Cena, ki jo za posamezno storitev prizna financer, se določi po statistični obdelavi stroškov, ki jih ima veliko število izvajalcev v zvezi s posamezno skupino medsebojno primerljivih obravnav, ki se jih v mnogih državah klasificira po sistemu DRG (<italic toggle="yes">angl.</italic> diagnose related groups). V povprečju so zajeti tako tisti, ki cilje dosegajo s cenejšimi alternativami, kot tisti, ki jih dosegajo z dražjimi, in tisti, ki iščejo različne kombinacije (t. i. case-mix) (<xref ref-type="bibr" rid="b10">10</xref>).</p>
      </sec>
      <sec id="s6"
           sec-type="Vloga smernic v epidemiologiji in problem pristranskega branja smernic">
         <label>6</label>
         <title>Vloga smernic v epidemiologiji in problem pristranskega branja smernic</title>
         <p>Ko govorimo o postopkih, ki naj bi se izvajali v javnem zdravstvu, je vedno treba upoštevati tudi epidemiološki vidik, saj mora biti do vsake storitve, ki se v javnem zdravstvu ponuja, pod enakimi pogoji, torej v isti fazi in stopnji bolezni, upravičen vsak prebivalec v razumnem času. Zato v javnem zdravstvu »postopek« ni samo proces, ki se odvije takrat, ko se bolnik znajde v ordinaciji, temveč tudi vsi ukrepi, ki zagotavljajo, da oseba z določeno zdravstveno težavo potrebno zdravstveno storitev tudi dobi. Smernice za reanimacijo nam v epidemiološkem smislu ne pomagajo dosti, če logistika ne omogoča, da bi pomoč prišla pravočasno. V pravnem smislu sicer ne obstaja iztožljiva pravica prebivalstva do recimo visoke stopnje preživetja miokardnega infarkta, ker »prebivalstvo« kot statistična skupina nima pravne sposobnosti in ne more vložiti tožbe proti državi ali posameznemu izvajalcu. Vendar pa slaba logistika poveča tveganje, da bo zaradi miokardnega infarkta umrl nekdo, ki ob pravočasnem in pravilnem ukrepanju ne bi. Izvajalec javne zdravstvene dejavnosti se v sodnih postopkih večinoma ne more učinkovito ubraniti z argumentom kadrovske ali prostorske podhranjenosti. Celo posamezni zdravnik se lahko ubrani le, če dokaže, da je bil v konkretni situaciji prisiljen triažirati, da je torej vse bolnike, ki so v istem času njegovo pomoč potrebovali, razvrstil v skupine glede na stopnjo nujnosti in da je obravnavo nekega bolnika odložil zato, ker je grozila večja nevarnost neki drugi osebi. Argument, da je vrstni red določil po administrativnem pravilu »kdor prej pride, prej dobi storitev«, na sodišču ne uspe, saj to, da je nekdo prišel prej, ne pomeni, da storitev prej tudi potrebuje. Izvajalec, ki je organizator javne službe, pa z argumentom preobremenjenosti svoje obrambe sploh ne more utemeljiti in je kriv praktično za vsako opustitev nepravočasne storitve (<xref ref-type="bibr" rid="b11">11</xref>).</p>
         <p>Izvajalci javne zdravstvene službe se torej znajdejo v hudi pravni stiski, ko bi po eni strani po smernicah morali zagotoviti določeno zdravstveno storitev, vendar je zaradi pomanjkanja virov ne morejo. Pride do neizogibnega konflikta med smernicami kot nekakšnim strokovnim aksiomom, v katerega ne bi smeli dvomiti, in dejstvom, da so viri za zagotavljanje zdravstvenih storitev vselej omejeni. Zato je potrebno stalno prilagajanje procesov epidemiološkemu stanju (torej potrebam po zdravstvenih storitvah), novim znanstvenim spoznanjem in racionalni uporabi razpoložljivih virov (<xref ref-type="bibr" rid="b12">12</xref>).</p>
         <p>Če recimo v smernicah piše, da se pri okužbi zgornjih dihal prvi teden ne daje antibiotik (<xref ref-type="bibr" rid="b13">13</xref>), v tej izjavi seveda ne piše, da mora zdravnik bolniku prvi dan okužbe zgornjih dihal priporočiti simptomatsko terapijo in 8. dan kontrolirati njeno učinkovitost. Raziskave so celo pokazale, da starši, ki v 50 % pred obiskom zdravnika pričakujejo, da bo otrok dobil antibiotik, niso manj zadovoljni s storitvijo, če antibiotika ne dobijo (<xref ref-type="bibr" rid="b14">14</xref>). Smernice je mogoče uresničiti na vrsto različnih načinov, med drugim tudi tako, da se opredeljene bolnike navadi, da prvi teden nezapletene okužbe dihal k zdravniku sploh ne hodijo. Ali pa da se bolnik naroči na prvi pregled čez en teden, ko bo lahko podal daljšo anamnezo in ko se bo že mogoče odločati bodisi o zaključku bolniške odsotnosti, bodisi o uvedbi antibiotika in podaljšanju odsotnosti.</p>
         <p>Pogosta napaka pri branju smernic je tudi ta, da glede neke težave obstaja veliko možnih pristopov, vendar učinkovitost nobenega ni podprta z dokazi. V takšnih primerih je v prvi vrsti potrebno pojasnilo o naravi bolezni in o tem, da učinkovitega zdravljenja zanjo nimamo. Za bolnika to ni novica, ki jo želi slišati, vendar se ji ne moremo izogniti s tem, da eksperimentiramo.</p>
         <p>Nadaljnja pogosta napaka so primeri, ko zdravniki najprej posežejo po postopku, podprtem na dokazih, in če ta ni uspešen, začnejo posegati po postopkih, ki z dokazi niso podprti (<xref ref-type="bibr" rid="b15">15</xref>). Gre za intuitivno željo bolniku za vsako ceno poskušati pomagati, in iščejo »čudežno zdravilo«. Čeprav je pristop videti altruističen in je bolnikom všečen, takšno postopanje v javnem zdravstvu poslabšuje dostopnost bolnikom, ki od istega zdravnika potrebujejo na dokazih utemeljen postopek, pa do njega zaradi omejenosti virov ne morejo pravočasno priti.</p>
         <p>Pristransko branje smernic je lahko tudi motiv za uvajanje nekakšnih neformalnih preventivnih programov, ki sami po sebi niso na dokazih podprti. Če recimo v smernicah piše, da pravočasno odkritje in ekscizija neke oblike raka zmanjša smrtnost zaradi te bolezni, to ne pomeni, da je treba vsakega prebivalca enkrat letno povabiti na presejalni program, dokler z dokazi ni podprto, da sistematični pregledi enkrat letno zmanjšajo smrtnost zaradi te konkretne oblike raka. Podoben primer je bilo priporočilo o presejalnem programu za nosečniško sladkorno bolezen, po katerem naj bi v Sloveniji testirali vse nosečnice (<xref ref-type="bibr" rid="b16">16</xref>), čeprav je bilo že leta 2001 znano, da učinkovitost takšnih presejalnih programov ni dovolj jasno izkazana (<xref ref-type="bibr" rid="b17">17</xref>) in je leta 2006 Svetovna zdravstvena organizacija izdelala merila, po katerih se potreba po takšnem testiranju presoja glede na obstoječe oziroma znane dejavnike tveganja (<xref ref-type="bibr" rid="b18">18</xref>).</p>
      </sec>
      <sec id="s7"
           sec-type="Konflikt interesov in problem pristranskega pisanja smernic">
         <label>7</label>
         <title>Konflikt interesov in problem pristranskega pisanja smernic</title>
         <p>Še več težav kot z branjem pa je s pristranskim pisanjem smernic. Avtorji so namreč pod stalnim pritiskom tako industrije kot kolegov, da določenim postopkom pripišejo večjo stopnjo znanstvene prepričljivosti, ker jo hočejo uporabiti kot argument v pogajanjih za pridobitev dodatnih javnih sredstev, zmogljivosti, kadrov in podobnega. Pri tem gre za dokaj kratkovidne interese, saj smo videli, da preveč popustljive smernice ustvarjajo odlične pogoje tako za odškodninske tožbe zoper zdravnike (neugoden izid sodnega postopka zaradi opustitve postopka, ki znanstveno ni prepričljiv) kot za nastanek brezizhodnih situacij, v katerih zdravnik zaradi omejenosti virov ne more zagotoviti tega, kar se po smernicah od njega pričakuje. Preveč popustljive smernice so torej predvsem v interesu industrije, raziskovalcev in ozke interesne skupine uporabnikov storitev (lobijev), njihove žrtve pa so izvajalci, pri njih zaposleni zdravniki, zdravstvene blagajne in predvsem bolniki, ki jim je javni zdravstveni sistem v prvi vrsti namenjen.</p>
         <p>Zato je potrebno uvesti nekatere varovalke, ki so povzete iz sistemskega mnenja Komisije za preprečevanje korupcije št. 06211–9/2012/23 z dne 03. 07. 2012 (<xref ref-type="bibr" rid="b19">19</xref>):</p>
         <list>
            <list-item>
               <label>•</label>
               <p>obveznost razkritij avtorjev smernic, njihovih zaposlitev, dohodkov ter povezav, zlasti z industrijo, in presoja obstoja konflikta interesov;</p>
            </list-item>
            <list-item>
               <label>•</label>
               <p>izločitev strokovnjakov iz komisij, ki smernice sprejemajo, če glede na razkritja obstaja dejanski konflikt interesov ali pa že videz obstoja konflikta interesov;</p>
            </list-item>
            <list-item>
               <label>•</label>
               <p>krepitev odgovornosti pripravljavcev smernic za doseganje javnozdravstvenih ciljev, med drugim tudi vzdrževanja čakalnih dob v razumnih mejah in zmanjševanja incidenc ali posledic stanj, ki jih smernice obravnavajo.</p>
            </list-item>
         </list>
         <p>Konflikt interesov je podan, ko je član komisije za smernice v pravnem ali ekonomskem odnosu z nekom, ki ima glede vsebine smernic svoj partikularni interes. Zakon o integriteti in preprečevanju korupcije navaja naslednji definiciji: nasprotje interesov so okoliščine, v katerih zasebni interes uradne osebe vpliva ali ustvarja videz, da vpliva na nepristransko in objektivno opravljanje njenih javnih nalog. Zasebni interes uradne osebe pa pomeni premoženjsko ali nepremoženjsko korist zanjo, za njene družinske člane in za druge fizične ali pravne osebe, s katerimi ima ali je imela osebne, poslovne ali politične stike (<xref ref-type="bibr" rid="b20">20</xref>).</p>
         <p>Ta interes ni nujno finančni; ima ga recimo tudi zdravnik, ki si obeta privlačnejše delovno mesto ali položaj ali delo, raziskovalec, ki bi z uresničevanjem smernice pridobil preiskovance ali sredstva za raziskave itd. Pomembno je poudariti, da samo dejstvo, da je nekdo dobil honorar od industrije, še ne dokazuje konflikta interesov. Pomembno je tudi to, ali je honorar sorazmeren vloženemu trudu, kako pogosto ga član komisije prejema in ali svoje honorarno delo enakomerno razporeja med različne deležnike, ali je plačan za objavo natančno določenega rezultata ipd. (<xref ref-type="bibr" rid="b21">21</xref>).</p>
         <p>Avtorji smernic se morajo zavedati, da ima skoraj vsako odstopanje v smernicah od na dokazih utemeljenih spoznanj za posledico premoženjsko korist izvajalcev, ki ponujajo v smernicah dopustne postopke, in njihove dobavitelje v industriji.</p>
         <p>Če je podan še naklep (torej namenoma izpuščena alternativa), pa je izpolnjen še drugi element (protipravno ravnanje), kar je že kaznivo dejanje. Tovrstne prakse je mogoče in potrebno preprečevati z ozaveščanjem in s kazenskimi pregoni, kajti sicer pisanje smernic postane priročno orodje za izrivanje konkurenčnih izvajalcev zdravstvene dejavnosti in netransparentno uresničevanje interesov lobističnih skupin.</p>
      </sec>
      <sec id="s8" sec-type="Utrjevanje uvajanja smernic v prakso">
         <label>8</label>
         <title>Utrjevanje uvajanja smernic v prakso</title>
         <sec id="s8.1" sec-type="Sistem financiranja">
            <label>8.1</label>
            <title>Sistem financiranja</title>
            <p>Tudi ob uvedenem sistemu smernic zdravnik ohrani avtonomijo pri izbiri vrste diagnosticiranja ali zdravljenja, ki jo bo ponudil bolniku. Zaradi pravne varnosti je sicer priporočljivo, da se odloči za eno, ki jih priporočajo smernice, vendar lahko izbere tudi katero drugo, če dovolj zanesljivo pričakuje, da z njo bolniku ne bo škodoval in da bo lahko v primeru tožbe dokazal, da je v zadostni meri poskrbel za njegovo varnost.</p>
            <p>Večje vznemirjenje nastane pri vprašanju, kdo nosi stroške, če zdravnik izbere dražjo alternativo. Vsekakor to ne bi smela biti zdravstvena zavarovalnica, ki bi morala plačati enako ceno, ne glede na izbrano metodo. Znotraj izvajalcev pa so prakse različne. Nekateri puščajo prosto odločitev zdravnikom, dokler se ti pri svojih odločitvah obnašajo racionalno in se za dražje metode odločajo le izjemoma. Kjer to ne zadostuje, izvajalci uvedejo strožja pravila in zahtevajo, da pred izbiro dražje metode zdravnik pridobi soglasje konzilija ali strokovnega vodstva zavoda.</p>
            <p>Seveda je bolniku vedno potrebno predstaviti vse metode, ki jih smernice dopuščajo. Bolnik si lahko prosto izbere katero koli metodo. Vendar bolnik s svojo izbiro ne more vplivati na stroške izvajalca. Če si izbere dražjo metodo, čeprav izvajalec dejavnosti meni, da je cenejša metoda zadostna, je treba bolnika obravnavati kot samoplačnika (izbira storitve, ki po mnenju pooblaščenega zdravnika ni potrebna – 7. točka 25. člena Pravil obveznega zdravstvenega zavarovanja), seveda ob predpostavki, da v samoplačniško obravnavo privoli (<xref ref-type="bibr" rid="b22">22</xref>,<xref ref-type="bibr" rid="b23">23</xref>).</p>
         </sec>
         <sec id="s8.2" sec-type="Klinične poti in njihova povezava s smernicami">
            <label>8.2</label>
            <title>Klinične poti in njihova povezava s smernicami</title>
            <p>Klinična pot je shematski načrt zaporedja postopkov in odločitev, ki jih izvajalec uporablja pri določenem kliničnem problemu. Smernice najlažje in najpopolneje zaživijo v praksi preko kliničnih poti. Po strukturi je klinična pot protokol, ki natančneje opisuje izvedbo smernic v lokalnem okolju glede na prisotne danosti. Kot standardiziran plan zdravstvene večdisciplinarne oskrbe prepoznava zaporedje kliničnih ukrepov, časovnih okvirov, mejnikov in pričakovanih rezultatov homogene skupine bolnikov. Smernice v splošnem pokrivajo več kliničnih problemov, medtem ko so klinične poti bolj osredotočene na posamezni problem ali njegov del. Zato so posamezne smernice praviloma povezane z več kliničnimi potmi (<xref ref-type="bibr" rid="b24">24</xref>).</p>
            <p>V primerjavi s smernicami je klinična pot precej bolj konkretizirana, saj vsebuje tudi korake, o katerih smernice ne določajo ničesar. Klinične poti zagotavljajo, da bolnika obravnavajo pravi strokovnjaki, v pravilnem vrstnem redu, na pravem mestu, ob pravem času, s primernimi sredstvi, s pravim izidom obravnave in skladno s potrebami in v zadovoljstvo bolnika (<xref ref-type="bibr" rid="b25">25</xref>).</p>
            <p>Včasih izvajalci od avtorjev smernic pričakujejo tudi odgovore na vprašanja, kako naj v organizacijskem ali finančnem smislu smernico uresničijo. Velikokrat to počnejo celo z ustvarjanjem konflikta interesov, da torej izrabljajo svoj položaj delodajalca zato, da član komisije, sicer zaposlen pri izvajalcu, doseže prilagoditev smernice klinični poti posameznega izvajalca. Vse te prakse so koruptivne in člani, ki so deležni takšnih pritiskov, bi se morali izločiti iz odborov. Smernice smejo obsegati le na dokazih podprta spoznanja, ne oziraje se na to, ali ti dokazi podpirajo prakso ali organizacijo določenega izvajalca in njegov proračun ali ne. V smernice ne vključujemo nečesa, kar se nam zdi smiselno ali logično, ni pa utemeljeno na dokazih. Smernice vedno dopuščajo več možnosti uresničitve. Iskanje teh možnosti je stvar izvajalcev in ne stvar avtorjev smernic. Tega v slovenskih razmerah ni lahko uvajati, saj smo vajeni rešitve in celo cilje javnega zdravstva prilagajati zatečeni organizaciji in modelom financiranja, namesto da bi bilo obratno.</p>
            <p>V Sloveniji je tudi zakoreninjena praksa prepisovanja poslovnih procesov vodilnih izvajalcev ali kar procesov, kot jih izvaja vodilni izvajalec (pogosto je to UKC Ljubljana), celo do te mere, da jih včasih želijo kar uporabljati kot smernice. To seveda ni na dokazih utemeljena klinična praksa, saj bi morali za takšno ugotovitev imeti študijo z močnimi dokazi, da je klinična pot takšnega izvajalca statistično pomembno učinkovitejša od povprečne prakse zdravstvenih institucij po svetu.</p>
         </sec>
         <sec id="s8.3" sec-type="Standardi in njihova povezava s smernicami">
            <label>8.3</label>
            <title>Standardi in njihova povezava s smernicami</title>
            <p>Po definiciji (SIST EN 45020) je standard dokument, ki nastane s konsenzom in ga odobri priznani organ. Določa pravila, smernice ali značilnosti za dejavnosti in njihove rezultate (<xref ref-type="bibr" rid="b26">26</xref>). Standardi so smernicam podobni v tem, da vsebujejo enostavno izjavo, ki pokriva določeno situacijo. Od smernic pa se razlikujejo predvsem v tem, da imajo poleg priporočilnega tudi predpisovalni del, ki določa:</p>
            <list>
               <list-item>
                  <label>•</label>
                  <p>kaj je treba narediti v določeni situaciji;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>včasih tudi to, kdo mora to narediti;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>kakšni so pričakovani rezultati oz. kazalci.</p>
               </list-item>
            </list>
            <p>Standardi so v bistvu nekakšen osnutek predpisa. Sestavljeni so tako, da jih je mogoče uporabiti kot predpis, vendar dobijo svojo obvezujočo naravo šele, ko se uvedejo z določenim predpisom, splošnim aktom neke organizacije ali pogodbo, torej s pravno obvezujočim dokumentom. Bistvena razlika med standardom in smernicami je v tem, da standard izvajalec uporablja bodisi zato, ker se je k temu sam zavezal (npr. s pogodbo, s ponudbo, z zavezujočo izjavo ipd.), bodisi zato, ker mu ga je predpisal nek organ s predpisom, splošnim aktom organizacije ipd., medtem ko smernice izvajalec uporablja zato, ker jih zaradi njene strokovne prepričljivosti težko ignorira.</p>
            <p>Od običajnega predpisa se standardi razlikujejo predvsem v tem, da vsebujejo tudi priporočilni del, na podlagi katerega so sprejeti. Medtem ko je predpis izključno stvar volje tistega, ki ga sprejema, in za svojo veljavnost ne potrebuje nobene objektivne utemeljitve, morajo standardi temeljiti na smernicah, torej na strokovnem konsenzu. Lahko bi rekli, da so standardi predpisi, ki zrastejo na podlagi spoznanj stroke. Dejstvo, da je izvajalec ravnal po standardu, namreč samo po sebi ne izključuje odškodninske odgovornosti, temveč je ta izključena ob enakih predpostavkah kot pri smernicah, torej ko ne obstaja prepričljivi dokaz, da bi drugačno (nestandardno) ravnanje škodljivo posledico preprečilo.</p>
            <p>Vloga standardov je predvsem v tem, da je na njihovi podlagi mogoče primerjati dva različna produkta ali dve različni storitvi med seboj. Standardi ne predstavljajo izčrpnega opisa, ki uporabniku standarda ne bi dopuščal nikakršne avtonomije glede načina izvedbe. Opredeljujejo samo minimalni nabor značilnosti, za katere v stroki obstaja konsenz, da so potrebne za to, da je neka storitev ali produkt to, kar izvajalec trdi, da je.</p>
            <p>V okviru javnega zdravstva je sprejem standardov potreben zlasti v dveh primerih:</p>
            <list>
               <list-item>
                  <label>•</label>
                  <p>ko izvajalec ali javni zdravstveni sistem bolniku želita zagotoviti nek konkreten postopek in je treba presoditi, ali ga je dobil, ali ne;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>ko je nek postopek razdeljen med več izvajalcev oziroma nosilcev in naslednji nosilec postopka ne more prevzeti, preden prejšnji del postopka ni dokončan v skladu s standardom.</p>
               </list-item>
            </list>
         </sec>
      </sec>
      <sec id="s9" sec-type="Prenos tujih smernic">
         <label>9</label>
         <title>Prenos tujih smernic</title>
         <p>Znanost je prepričljiva sama po sebi in njene ugotovitve ne poznajo nacionalnih ali političnih meja. Zato pogosto sledimo načelu, da smernic ni potrebno izdelati v vsaki državi posebej in da ne bomo veliko zgrešili, če bomo prepisali smernice, ki jih je izdelal že nekdo drug.</p>
         <p>Vendar moramo pri tem ločiti dve ravni:</p>
         <list>
            <list-item>
               <label>•</label>
               <p>velike multicentrične študije, ki so podlaga tujim smernicam in katerih verodostojnosti je precej težko oporekati;</p>
            </list-item>
            <list-item>
               <label>•</label>
               <p>organe, ki določeno priporočilo sprejmejo.</p>
            </list-item>
         </list>
         <p>Tuje smernice in priporočila imajo v slovenskem pravnem prostoru značaj dobrega preglednega članka. To pomeni, da so lahko eden od virov, iz katerih se črpajo slovenska priporočila, in tudi vodilo, ki ga lahko uporabijo slovenski praktiki ob odsotnosti slovenskih priporočil; ne smejo pa biti edini vir. Slovenski organi, ki sprejemajo smernice, morajo pregledati vso svetovno verodostojno literaturo, vključno s priporočili in smernicami iz tujih držav, in nato iz vsega tega izdelati svoje priporočilo kot samostojno delo. Pogledati je treba rezultate slovenskih študij in jih v priporočila vključiti, ko se statistično pomembno ne razlikujejo od tistih iz svetovne literature. Če se statistično pomembno razhajajo, pa se je treba do njih ustrezno opredeliti in ugotoviti, ali so razhajanja posledica manjšega vzorca slovenske študije ali večje specifičnosti slovenske populacije. O specifičnosti lahko govorimo šele takrat, ko je študija, narejena na slovenskem vzorcu, glede metodologije in velikosti vzorca vsaj približno enakovredna referenčnih študijam iz tujine. Ko se slovenske študije statistično pomembno razlikujejo od tujih na majhnem vzorcu, pa ne bi smele vplivati na vsebino nacionalnih priporočil, ker je razlika bolj verjetno posledica omejenosti pri vzorčenju ali metodološke napake kot biološke razlike prebivalcev Slovenije od ostalih Evropejcev ali Zemljanov.</p>
         <p>Omeniti je treba tudi razne evropske smernice. Te se lahko neposredno uporabljajo v čezmejnih projektih, npr. pri odločitvah o financiranju projektov institucij EU. Neposredno uporabne bi lahko bile tudi pri čezmejnih zdravstvenih storitvah, recimo ko izvajalec iz ene države pridobiva bolnike na ozemlju druge države. V slovenskem nacionalnem sistemu (npr. pri odločitvah o financiranju slovenske države ali ZZZS) pa imajo – enako kot vsa ostala tuja priporočila – zgolj značaj dobrega preglednega članka in jih je treba pri oblikovanju slovenskih nacionalnih smernic presojati v kontekstu ostalih razpoložljivih virov.</p>
         <p>Zelo tehtno je vprašanje, ali je za Slovenijo smiselno, da ima lasten sistem smernic, ob tem ko je glede na dokumentarne vire, ki so podlaga zanje, pravzaprav težko pričakovati, da se bodo bistveno razlikovale od tistih iz drugih držav. Po drugi strani pa je vprašanje, ali se temu sploh lahko izognemo, če nočemo, da bo nekdo delal po španskih, drugi po kanadskih in tretji po avstralskih smernicah. Ta težava se po navadi rešuje z internalizacijo tujih ali mednarodnih smernic in sicer tako, da organ, ki je pristojen za sprejemanje slovenskih smernic, mednarodne smernice sprejme še kot nacionalne. Vendar pri tem obstaja nekaj predpogojev:</p>
         <list>
            <list-item>
               <label>•</label>
               <p>smernice morajo ustrezati vsem standardom, ki bi jim zadostile slovenske klinične oziroma nacionalne smernice;</p>
            </list-item>
            <list-item>
               <label>•</label>
               <p>mednarodnemu priporočilu mora biti dodana izjava slovenskega organa, da se mednarodno priporočilo šteje tudi kot slovensko nacionalno priporočilo;</p>
            </list-item>
            <list-item>
               <label>•</label>
               <p>internalizirana priporočila se morajo ujemati, ali vsaj ne smejo biti v nasprotju, z izsledki slovenske strokovne literature, ki jo je treba pred sprejemom tujih smernic temeljito pregledati.</p>
            </list-item>
         </list>
         <p>To je dokaj praktičen pristop, saj v tem primeru ni več razlik med standardi na notranjem in čezmejnem trgu.</p>
      </sec>
      <sec id="s10" sec-type="Pristojni organi za sprejemanje smernic v Sloveniji">
         <label>10</label>
         <title>Pristojni organi za sprejemanje smernic v Sloveniji</title>
         <p>Zakon o zdravstveni dejavnosti (ZZDej) ne vsebuje terminov »smernice« ali »priporočila«, zato je treba pristojnost za pisanje smernic smiselno izluščiti iz 74. člena ZZDej. Ta določa, da strokovno doktrino o krepitvi zdravja, preprečevanju, ugotavljanju, zdravljenju, zdravstveni negi in rehabilitaciji zbolelih, poškodovanih in osebah z motnjami v telesnem in duševnem razvoju oblikujejo razširjeni strokovni kolegiji (RSK). RSK je po ZZDej najvišji strokovni organ na posameznem področju, ki usklajuje predloge klinik, strokovnih združenj in zbornic, visokošolskih zavodov, zdravstvenih zavodov ter posameznih strokovnjakov. Iz tega besedila bi sklepali, da imajo dokumenti, ki jih izdelajo RSK, status priporočila, dokler jih Zdravstveni svet ne potrdi.</p>
         <p>Za tranzicijo priporočil v smernice pa je po prvem odstavku 75. člena ZZDej pristojen Zdravstveni svet. Po tej določbi strokovne predloge RSK, ki vplivajo na vsebino in obseg zdravstvenega varstva, s tem pa na zdravstveno politiko in financiranje zdravstvenega varstva, obravnava in potrjuje Zdravstveni svet kot najvišji strokovnousklajevalni organ na področju zdravstvenega varstva. Zdravstveni svet oblikuje vsebino zdravstvenih programov s stališča njihove izvedljivosti, enakomernega razvoja vseh strok in načela enake dostopnosti. Od razširjenih strokovnih kolegijev lahko zahteva, da strokovno doktrino prilagodijo ekonomskim možnostim države ali da predlagajo izvajanje programov po prioritetah in v omejenem obsegu. Zdravstveni svet se oblikuje pri ministrstvu, pristojnem za zdravje, iz predstavnikov zdravstvene stroke, iz vrst svetnikov, višjih svetnikov, fakultetnih učiteljev in drugih priznanih strokovnjakov s področja zdravstvenega varstva, zdravstvene ekonomike in organizacije zdravstvenega varstva (<xref ref-type="bibr" rid="b27">27</xref>).</p>
         <p>Slovensko zdravniško društvo je izdelalo predlog poti sprejemanja strokovnih priporočil, kliničnih smernic in nacionalnih smernic, ki ga je dne 7. 3. 2018 potrdil tudi Zdravstveni svet (<xref ref-type="bibr" rid="b28">28</xref>). Klinične smernice in priporočila pripravijo delovne skupine v okviru strokovnih združenj, društev in sekcij, ki so organizirane v Zvezi društev – Slovensko zdravniško društvo (SZD). Pripravljeno besedilo se potrdi na srečanju združenj, društev ali sekcij. Nato gredo priporočilo oziroma klinične smernice v obravnavo strokovnemu svetu za določeno področje, ki ju dokončno uskladi in oblikuje ter posreduje v obravnavo Glavnemu strokovnemu svetu SZD. Ko ju ta potrdi, je besedilo lahko objavljeno v Zdravniškem vestniku.</p>
         <p>Osnutek nacionalnih smernic najprej obravnava in potrdi RSK za določeno področje, nato pa se pošlje v obravnavo in potrditev Zdravstvenemu svetu. Pred obravnavo se oblikuje delovna skupina za smernice, ki pripravi ekonomsko oceno virov, Zdravstveni svet pa lahko po potrebi naroči predlagatelju, da svoj predlog dopolni.</p>
         <p>Ker nacionalne smernice – za razliko od kliničnih smernic in priporočil – ne izražajo le konsenza stroke, temveč odgovarjajo na vprašanje odločevalca, ki ga zanimajo pravni ali finančni vidiki obravnave določenega medicinskega vprašanja, v Sloveniji potrebujemo nek organ, ki bi upošteval tudi te vidike, saj strokovni sveti in njihovi člani ne nosijo odgovornosti za financiranje zdravstva. Vprašanje pa je, ali je Zdravstveni svet najboljša rešitev, ker zaradi svojega delovanja v okviru Ministrstva za zdravje ne daje zadostnega videza neodvisnosti in nepristranskosti, saj njegove člane imenuje minister s soglasjem Vlade. Poleg tega 1. odst. 7. člena Pravilnika o zdravstvenem svetu mandat njegovih članove veže na mandat ministra za zdravje (<xref ref-type="bibr" rid="b29">29</xref>). Primerneje bi bilo, da bi smernice sprejemale neodvisne institucije, npr. neodvisna javna agencija ali inštitut za kakovost v zdravstvu. Britanski NICE (National Institute for Health and Care Excellence) je za svoje delo sicer tudi odgovoren ministrstvu za zdravje, vendar v operativnem smislu deluje neodvisno od njega (<xref ref-type="bibr" rid="b30">30</xref>). V ZDA smernice sprejema Agency for Healthcare and Quality (AHRQ), ki deluje kot neodvisno telo v sestavi ministrstva za zdravje (<xref ref-type="bibr" rid="b31">31</xref>). V Nemčiji smernice sprejema nekakšna neodvisna mešana komisija Gemeinsamer Bundesauschuss, ki je po tradiciji nemškega zdravstvenega sistema sestavljena iz deležnikov pri zagotavljanju zdravstvenega varstva, torej zdravstvenih zavarovalnic in izvajalcev zdravstvene dejavnosti (<xref ref-type="bibr" rid="b32">32</xref>). Podobno telo, imenovano Haute Autorité de Santé (HAS), obstaja tudi v Franciji, prav tako iz deležnikov na področju zdravstva, financirajo pa se iz financerjev francoskega javnega zdravstva, torej od države in zavarovalnic (<xref ref-type="bibr" rid="b33">33</xref>).</p>
      </sec>
   </body>
   <back>
      <ref-list>
         <ref id="b1">
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>US Preventive Services Task Force</collab>
                    </person-group>. 
                    <source>GRADE definitions</source>. 
                    <year>2016</year>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>]. 
                    <comment>Available from:<uri>https://www.uspreventiveservicestaskforce.org/Page/Name/grade-definitions</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b2">
            <mixed-citation publication-type="webpage">
                    <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                    <source>Levels of Evidence. Centre for Evidence Based Medicine</source>.
                    <year>2016</year>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b3">
            <mixed-citation publication-type="webpage">
                    <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                    <source>BMJ clinical evidence</source>. 
                    <year>2016</year> 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>http://clinicalevidence.bmj.com/x/set/static/ebm/learn/665072.html</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b4">
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Aaron</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Harris</surname>
                     <given-names>MP</given-names>
                  </name>,
                        <name name-style="western">
                     <surname>Lauri</surname>
                     <given-names>AH</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Qaseem </surname>
                     <given-names>A</given-names>
                  </name>; 
                        <collab>High Value Care Task Force of the American College of Physicians and for the Centers for Disease Control and Prevention</collab>.
                    </person-group>. 
                    <article-title>Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults</article-title>.
                    <source>Ann Intern Med</source>.
                    <year>2016</year>;
                    <volume>164</volume>(
                    <issue>6</issue>):
                    <fpage>415</fpage>–
                    <lpage>34</lpage>. 
                    <pub-id pub-id-type="doi">10.7326/M15-1840</pub-id>
                    <pub-id pub-id-type="pmid">    26785402</pub-id>
                    <issn>0003-4819</issn>
                </mixed-citation>
         </ref>
         <ref id="b5">
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>American Academy of Pediatrics</collab>
                    </person-group>. Standards, Recommendations, Guidelines, and Regulations.  
                    <year>2016</year>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>www.healthychildcare.org/StandardsRegulations.html</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b6">
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>World Health Organization</collab>
                    </person-group>. 
                    <article-title>WHO guidelines approved by the Guidelines Review Committee</article-title>. 
                    <year>2016</year>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>http://www.who.int/publications/guidelines/en/</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b7">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Schwartz</surname>
                     <given-names>PJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Breithardt</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Howard</surname>
                     <given-names>AJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Julian</surname>
                     <given-names>DG</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Rehnqvist Ahlberg</surname>
                     <given-names>N</given-names>
                  </name>
                    </person-group>. 
                    <article-title>The legal implications of medical guidelines - Task Force of the European Society of Cardiology</article-title>. 
                    <source>Eur Heart J</source>. 
                    <year>1999</year>
                    <month>Aug</month>;
                    <volume>20</volume>(
                    <issue>16</issue>):
                    <fpage>1152</fpage>–
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.1053/euhj.1999.1677</pub-id>
                    <pub-id pub-id-type="pmid">10448023</pub-id>
                    <issn>0195-668X</issn>
                </mixed-citation>
         </ref>
         <ref id="b8">
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Grams</surname>
                     <given-names>HA</given-names>
                  </name>,
                    </person-group>. 
                    <source>Leitlinien: Begriff, Entwicklung, Bedeutung für die Aufklärung und die ärztliche Handlungsfreiheit</source>.
                    <year>2016</year>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>https://berliner-anwaltsverein.de/files/media/download/Arbeitsgruppe%20Medizinrecht%20Archiv/AGMED_2012_Leitlinien-2012.pdf</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b9">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Hurwitz</surname>
                     <given-names>B</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Guidelines and jurisprudence: advice, guidance or regulation?</article-title> 
                    <source>Epidemiol Prev</source>. 
                    <year>1998</year>
                    <month>Apr-Jun</month>;
                    <volume>22</volume>(
                    <issue>2</issue>):
                    <fpage>85</fpage>–
                    <lpage>93</lpage>.
                    <pub-id pub-id-type="pmid">9789380</pub-id>
                    <issn>1120-9763</issn>
                </mixed-citation>
         </ref>
         <ref id="b10">
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>German hospital service</collab>
                    </person-group>. 
                    <article-title>DRG tables</article-title>.
                    <year>2017</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>http://www.drg.german-hospital-service.com/</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b11">
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bitterman</surname>
                     <given-names>RA</given-names>
                  </name>; 
                        <collab>Overcrowded Emergency Department Leads to Lawsuit Over EMTALA</collab>
                    </person-group>. 
                    <article-title>AHC Media</article-title>.
                    <year>2016</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>https://www.ahcmedia.com/articles/16249-overcrowded-emergency-department-leads-to-lawsuit-over-emtala</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b12">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Saarni</surname>
                     <given-names>SI</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Gylling</surname>
                     <given-names>HA</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Evidence based medicine guidelines: a solution to rationing or politics disguised as science?</article-title>
                    <source>J Med Ethics</source>. 
                    <year>2004</year>
                    <month>Apr</month>;
                    <volume>30</volume>(
                    <issue>2</issue>):
                    <fpage>171</fpage>–
                    <lpage>5</lpage>. 
                    <pub-id pub-id-type="doi">10.1136/jme.2003.003145</pub-id>
                    <pub-id pub-id-type="pmid">15082812</pub-id>
                    <issn>0306-6800</issn>
                </mixed-citation>
         </ref>
         <ref id="b13">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Wong</surname>
                     <given-names>DM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Blumberg</surname>
                     <given-names>DA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lowe</surname>
                     <given-names>LG</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Guidelines for the Use of Antibiotics in Acute Upper Respiratory Tract Infections</article-title>.
                    <source>Am Fam Physician</source>. 
                    <year>2006</year>
                    <month>Sep</month>;
                    <volume>74</volume>(
                    <issue>6</issue>):
                    <fpage>956</fpage>–
                    <lpage>66</lpage>.
                    <pub-id pub-id-type="pmid">17002029</pub-id>
                    <issn>0002-838X</issn>
                </mixed-citation>
         </ref>
         <ref id="b14">
            <mixed-citation publication-type="journal">
                        <person-group person-group-type="author">
                            <name name-style="western">
                     <surname>Wong</surname>
                     <given-names>DM</given-names>
                  </name>, 
                            <name name-style="western">
                     <surname>Blumberg</surname>
                     <given-names>DA</given-names>
                  </name>, 
                            <name name-style="western">
                     <surname>Lowe</surname>
                     <given-names>LG</given-names>
                  </name>
                        </person-group>. 
                        <article-title>Guidelines for the Use of Antibiotics in Acute Upper Respiratory Tract Infections</article-title>.
                        <source>Am Fam Physician</source>. 
                        <year>2006</year>
                        <month>Sep</month>;
                        <volume>74</volume>(
                        <issue>6</issue>):
                        <fpage>956</fpage>–
                        <lpage>66</lpage>.
                        <pub-id pub-id-type="pmid">17002029</pub-id>
                        <issn>0002-838X</issn>
                    </mixed-citation>
         </ref>
         <ref id="b15">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Elgizouli</surname>
                     <given-names>MA</given-names>
                  </name>
                    </person-group>. 
                    <article-title>What’s a good doctor and how do you make one? Medical profession needs input from belief in humanity and ethics</article-title>. 
                    <source>BMJ</source>. 
                    <year>2002</year>
                    <month>Sep</month>;
                    <volume>325</volume>(
                    <issue>7366</issue>):
                    <fpage>711</fpage>. 
                    <pub-id pub-id-type="doi">10.1136/bmj.325.7366.711</pub-id>
                    <pub-id pub-id-type="pmid">12358023</pub-id>
                    <issn>0959-8138</issn>
                </mixed-citation>
         </ref>
         <ref id="b16">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Krajnc</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Zavratnik</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Čokolič</surname>
                     <given-names>M</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Nosečnostna sladkorna bolezen</article-title>. 
                    <source>Medicinski mesečnik</source>
                    <year>2008</year>;
                    <volume>4</volume>:
                    <fpage>30</fpage>–
                    <lpage>6</lpage>.
                </mixed-citation>
         </ref>
         <ref id="b17">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Virjee</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Robinson</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Johnston</surname>
                     <given-names>D G</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Screening for diabetes in pregnancy</article-title>. 
                    <source>J R Soc Med</source>. 
                    <year>2001</year>
                    <month>Oct</month>;
                    <volume>94</volume>(
                    <issue>10</issue>):
                    <fpage>502</fpage>–
                    <lpage>9</lpage>.
                    <pub-id pub-id-type="doi">10.1177/014107680109401003</pub-id>
                    <pub-id pub-id-type="pmid">11581342</pub-id>
                    <issn>0141-0768</issn>
                </mixed-citation>
         </ref>
         <ref id="b18">
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>World Health Organization</collab>
                    </person-group>. 
                    <article-title>Diagnostic Criteria and Classification of Hyperglykaemia First Detected in Pregnancy</article-title>.
                    <year>2017</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>http://apps.who.int/iris/bitstream/10665/85975/1/WHO_NMH_MND_13.2_eng.pdf?ua=1</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b19">
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Klemenčič</surname>
                     <given-names>G</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Sistemsko načelno mnenje glede krepitve in omejevanja nasprotja interesov pri delovanju različnih komisij, svetov in delovnih skupin, v katerih sodelujejo posamezniki, ki niso zaposleni v javnem sektorju</article-title>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>https://www.kpk-rs.si/upload/datoteke/dopolnjeno%20sistemsko%20na%C4%8Delno%20mnenje%20183.pdf</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b20">
            <mixed-citation publication-type="journal">
                    <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                    <article-title>Zakon o integriteti in preprečevanju korupcije</article-title>.
                    <source>Ur l RS</source>. 
                    <year>2011</year>(
                    <issue>69</issue>) 
                </mixed-citation>
         </ref>
         <ref id="b21">
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>National Institute for Health and Care Excellence</collab>
                    </person-group>. Policy on Conflicts of Interest.
                    <year>2017</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>https://www.nice.org.uk/Media/Default/Get-involved/Fellows%20and%20scholars%20unsecure/Conflicts-of-interest-policy.pdf</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b22">
            <mixed-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                <article-title>Pravila obveznega zdravstvenega zavarovanja</article-title>.
                <source>Ur l RS</source>. 
                <year>1994</year>(
                <issue>69</issue>),  
                <year>1996</year>(
                <issue>39</issue>),  
                <year>1996</year>(
                <issue>70</issue>),  
                <year>1997</year>(
                <issue>47</issue>),  
                <year>1998</year>(
                <issue>3</issue>),  
                <year>1998</year>(
                <issue>51</issue>), 
                <year>1998</year>(
                <issue>73</issue>), 
                <year>1999</year>(
                <issue>6</issue>),
                <year>2000</year>(
                <issue>61</issue>),
                <year>2000</year>(
                <issue>64</issue>),
                <year>2002</year>(
                <issue>59</issue>),
                <year>2003</year>(
                <issue>18</issue>),
                <year>2003</year>(
                <issue>30</issue>),
                <year>2003</year>(
                <issue>35</issue>),
                <year>2003</year>(
                <issue>78</issue>),
                <year>2004</year>(
                <issue>84</issue>),
                <year>2005</year>(
                <issue>44</issue>),
                <year>2006</year>(
                <issue>86</issue>),
                <year>2006</year>(
                <issue>90</issue>),
                <year>2007</year>(
                <issue>64</issue>),
                <year>2008</year>(
                <issue>33</issue>),
                <year>2009</year>(
                <issue>7</issue>).
                </mixed-citation>
         </ref>
         <ref id="b23">
            <mixed-citation publication-type="journal">
                    <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                    <article-title>Zakon o pacientovih pravicah</article-title>.
                    <source>Ur l RS</source>. 
                    <year>2008</year>(
                    <issue>15</issue>).
                </mixed-citation>
         </ref>
         <ref id="b24">
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Geršak</surname>
                     <given-names>K</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Fras</surname>
                     <given-names>Z</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Rems</surname>
                     <given-names>M</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Ali vemo, kakšne morajo biti dobre klinične smernice?</article-title>
                    <source>Zdrav Vestn</source>. 
                    <year>2016</year>;
                    <volume>85</volume>:(
                    <issue>1</issue>)
                    <fpage>6</fpage>–
                    <lpage>14</lpage>.
                    <issn>0350-0063</issn>
                </mixed-citation>
         </ref>
         <ref id="b25">
            <mixed-citation publication-type="book">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Marušič</surname>
                     <given-names>B</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Simčič</surname>
                     <given-names>B</given-names>
                  </name>
                    </person-group>. 
                    <source>Priročnik za oblikovanje kliničnih poti</source>.
                    <publisher-loc>Ljubljana</publisher-loc>:
                    <publisher-name>Ministrstvo za zdravje</publisher-name>;
                    <year>2009</year>. pp.
                    <fpage>6</fpage>–
                    <lpage>7</lpage>.
                    <isbn>978–961–6523–38–7</isbn>
                </mixed-citation>
         </ref>
         <ref id="b26">
            <mixed-citation publication-type="webpage">
                    <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                    <source>Izvozno okno</source>. 
                    <year>2017</year>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2019-11-27">cited 2019 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>http://www.izvoznookno.si/Dokumenti/Mednarodno_trgovanje/Standardi_in_standardizacija_8426.aspx</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b27">
            <mixed-citation publication-type="journal">
                        <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                <article-title>Zakon o zdravstveni dejavnosti</article-title>.
                        <source>Ur l RS</source>. 
                        <year>2005</year>(
                        <issue>23</issue>),  
                        <year>2008</year>(
                        <issue>15</issue>),  
                        <year>2008</year>(
                        <issue>77</issue>),  
                        <year>2012</year>(
                        <issue>40</issue>),  
                        <year>2013</year>(
                        <issue>14</issue>),  
                        <year>2016</year>(
                        <issue>88</issue>), 
                        <year>2017</year>(
                        <issue>64</issue>).
                    </mixed-citation>
         </ref>
         <ref id="b28">
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>Ministrstvo za zdravje, Zdravstveni svet</collab>.
                    </person-group>.   
                        <source>Zapisnik seje Zdravstvenega sveta 1</source>.
                    <year>2018</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2019-11-27">cited 2019 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>http://www.mz.gov.si/fileadmin/mz.gov.si/pageuploads/zdravstveni_svet/ZS_18/zapisniki_2018/zapisnik_1-18-ZS.pdf</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b29">
            <mixed-citation publication-type="journal">
                    <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                    <article-title>Pravilnik o Zdravstvenem svetu</article-title>.
                    <source>Ur l RS</source>. 
                    <year>1988</year>(
                    <issue>1</issue>),  
                    <year>2006</year>(
                    <issue>40</issue>),  
                    <year>2009</year>(
                    <issue>8</issue>),  
                    <year>2011</year>(
                    <issue>11</issue>),  
                    <year>2012</year>(
                    <issue>48</issue>)
                </mixed-citation>
         </ref>
         <ref id="b30">
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>National Institute for Health and Care Excellence</collab>
                    </person-group>. 
                    <source>Who we are</source>. 
                    <year>2017</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>https://www.nice.org.uk/about/who-we-are</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b31">
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>Agency for Healthcare Research and Quality</collab>
                    </person-group>. 
                    <source>About AHRQ</source>. 
                    <year>2017</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>https://www.ahrq.gov/cpi/about/index.html</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b32">
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>Gemeinsamer Bundesausschuss</collab>
                    </person-group>. 
                    <source>Der Gemeinsame Bundesausschuss stellt sich vor</source>. 
                    <year>2017</year>.  
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>https://www.g-ba.de/institution/struktur/</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b33">
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>Haute Autorité de Santé</collab>
                    </person-group>. 
                    <source>Organisation de la HAS</source>. 
                    <year>2017</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>http://www.has-sante.fr/portail/jcms/c_412227/fr/organisation-de-la-has</uri>
               </comment>.
                </mixed-citation>
         </ref>
      </ref-list>
   </back>
   <sub-article id="article-en" xml:lang="en" article-type="other">
      <front-stub>
         <article-categories>
            <subj-group subj-group-type="discipline" xml:lang="en">
               <subject>Medicine and health sciences</subject>
               <subj-group>
                  <subject>Public health (occupational medicine)</subject>
               </subj-group>
            </subj-group>
            <subj-group subj-group-type="article-type" xml:lang="en">
               <subject>Professional article</subject>
            </subj-group>
            <subj-group subj-group-type="heading" xml:lang="en">
               <subject>Public health (occupational medicine)</subject>
            </subj-group>
         </article-categories>
         <title-group>
            <article-title xml:lang="en">The importance and legal status of the recommendations and guidelines</article-title>
            <alt-title alt-title-type="running-head" xml:lang="en">Pomen in pravni status priporočil in smernic</alt-title>
         </title-group>
         <contrib-group>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Popovič</surname>
                  <given-names>Bojan</given-names>
               </name>
               <xref ref-type="aff" rid="en-aff1">1</xref>
               <xref ref-type="corresp" rid="en-corr"/>
            </contrib>
         </contrib-group>
         <aff id="en-aff1" xml:lang="en">
            <label>1</label>
            <institution>Dermadent d.o.o., Ljubljana, Slovenia</institution>
         </aff>
         <history>
            <date date-type="received">
               <day/>
               <month/>
               <year/>
            </date>
            <date date-type="accepted">
               <day/>
               <month/>
               <year/>
            </date>
         </history>
         <abstract xml:lang="en">
            <title>Abstract</title>
            <p>Guidelines are a scientific contribution based on the consensual recommendations with a high quality and level of evidence aimed at giving high quality answers to decision makers, especially health care providers and payors. Guidelines are not legally binding, but because of the legal principle of due diligence they are difficult to ignore when decisions are made. Authors of guidelines must disclose any actual or potential conflict of interest. Foreign guidelines are considered as recommendations in Slovenia and cannot be directly used as Slovenian guidelines until Slovenian studies are considered. In Slovenia, the recommendations and clinical guidelines are prepared by professional medical associations and approved by professional committees and the Main Professional Committee established by the Slovenian Medical Association. Currently, the Health Council at the Ministry of Health is responsible to approve the national guidelines, but an independent agency would be more appropriate.</p>
         </abstract>
      </front-stub>
      <body>
         <sec id="en-s1" sec-type="From research to recommendations">
            <label>1</label>
            <title>From research to recommendations</title>
            <p>Medicine is a scientific discipline based on scientific knowledge and findings. In science, there is no such thing as a formal supreme authority that would adopt laws which would then be binding on all. The starting point of scientific research is a hypothesis, the claim made by the researcher, who attempts to either confirm or deny it in the course of the research process. A confirmed hypothesis becomes a theory or the authors’ position, and as such one of the possible explanations of the investigated phenomenon. Theories then become the subject of scientific debate in which different researchers test it under different conditions and in different populations until various professional associations have reached a certain consensus. Positions that represent the opinion of official representatives of professional medical associations or professional medical organisations, but which have not yet been fully prepared in accordance with standard established criteria for the systematic review and evidence-based evaluation, are referred to as clinical position statements (adapted from <italic toggle="yes">Predlog</italic>
               <italic toggle="yes"> poti sprejemanja strokovnih priporočil, kliničnih smernic in nacionalnih smerni</italic> / <italic toggle="yes">Proposal</italic>
               <italic toggle="yes"> of the procedure for adopting expert recommendations, clinical guidelines and</italic>
               <italic toggle="yes"> national guidelines,</italic> Slovenian Medical Association, a letter to the Health Council, No. 18–18/1 of 30 January 2018, hereinafter the SMA Proposal).</p>
            <p>In order to further objectivise the credibility of positions, formal and standardised adoption systems have been developed, which are also carried out by professional medical associations, in which, in addition to the findings of scientific research, the already existing clinical and international guidelines should also be taken into account, which in practice means that they are backed by a significantly larger number of studies generally carried out on an international level and in a significantly larger population and a wider geographical area, over a longer period of time, thus having a higher level of credibility than positions. According to the SZD Proposal, such texts are referred to as <italic toggle="yes">professional recommendations</italic>. However, even expert recommendations do not yet include a systematic overview of international and national professional literature with documented evidence evaluation, and therefore not all of them are equally trustworthy. According to U:S: Preventive Services Task Force (USPSTF), the quality of recommendations is ranked as A, B, C, D, I, which reflects the net effect (i.e. the risk/benefit ratio) of the implementation of a particular recommendation in practice, taking into account the number and size of studies that served as a basis for that recommendation (<xref ref-type="bibr" rid="en-b1">1</xref>). Similar such systems are the Oxford CEBM Levels of Evidence (<xref ref-type="bibr" rid="en-b2">2</xref>) and the GRADE system (Grading of Recommendations Assessment, Development and Evaluation) (<xref ref-type="bibr" rid="en-b3">3</xref>), which classify positions according to the quality of their evidence.</p>
         </sec>
         <sec id="en-s2" sec-type="Recommendations structure">
            <label>2</label>
            <title>Recommendations structure</title>
            <p>A recommendation is a consensual agreement of a large number of experts working within a particular professional association, regarding a simple and clear statement consisting of two sentences, linked to each other with the word “should” or “should not”. While the first sentence describes the situation, the second one refers to either desired (“should”) or undesirable (“should not”) conduct in such situation. Example: “Clinicians should not carry out tests or initiate antibiotic therapy in patients with bronchitis, unless pneumonia is suspected” (<xref ref-type="bibr" rid="en-b4">4</xref>).</p>
            <p>This is then furnished by argumentation, whereby the authors of the recommendation in the introductory part explain the motifs for their implementation along with the main epidemiological indicators. This is followed by a description of the standardised methodology with the list of databases from which the authors obtained their data or evidence. Of course, there should also be a list of literature and sources enclosed, including the already existing clinical and international guidelines.</p>
            <p>An important integral part of recommendations is the liability clause. In their recommendations, authors generally exclude their liability for any damage that may result from the use of the recommendations. This is however logical since the document is non-binding, and it is up to the practitioner to assess its applicability and sensibility in the particular case.</p>
         </sec>
         <sec id="en-s3" sec-type="From recommendations to guidelines">
            <label>3</label>
            <title>From recommendations to guidelines</title>
            <p>Guidelines are recommendations that form the basis for elaborating a particular strategy or policy. They differ from recommendations primarily in that the latter are not addressed to anyone in particular and on their own do not have practical effects while the guidelines are those recommendations used by the decision maker or the performer uses in planning or carrying our their activities, strategies or decisions (<xref ref-type="bibr" rid="en-b5">5</xref>). The World Health Organisation explicitly states that recommendations with an impact on the implementation of public policies or clinical practice should be regarded as guidelines (<xref ref-type="bibr" rid="en-b6">6</xref>). The reasons why a decision maker would need guidelines are different. The following two reasons, however, are most frequent:</p>
            <list>
               <list-item>
                  <label>•</label>
                  <p>the management of legal risks, i.e. unfavourable outcome of legal procedures that may befall the contracting authority of the guidelines, and</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>deciding on the financing of programmes.</p>
               </list-item>
            </list>
            <p>Since guidelines are documents that have both legal and economic effects, of course, not every recommendation can be deemed to be a guideline.</p>
            <p>In the first case, the decision makers (usually the healthcare providers) want to know which procedures can be reasonably expected to prevent damage as a basis of damage liability. Therefore, they are interested in those recommendations that are credible enough to enable a potential victim to prove any lack of due diligence if the healthcare provider failed to respect them. In the SZD proposal endorsed by the Health Council such recommendations are referred to as clinical guidelines, and this term applies only to those recommendations that are based on the highest level of evidence quality available at a given moment, and which were prepared through a multidisciplinary cooperation of various experts and other interested stakeholders, usually also representatives of patient organisations.</p>
            <p>The second case is associated with the definition of public healthcare. This is a system that ensures everyone, without discrimination, access to necessary and professionally justified health services within a reasonable time. Thus, the public healthcare system must at the macro level ensure everyone, in essence, exactly what each individual healthcare provider must provide to an individual patient at the micro level. The organizer of public healthcare needs to know which healthcare services or procedures should be made available to the users in order not to violate the definition of public healthcare. In the SZD proposal such recommendations are referred to as <italic toggle="yes">national guidelines</italic>. They must also include an economic assessment of resources (personnel, equipment and premises), logistics or implementation and risk management.</p>
            <p>There should be no major differences between the clinical and national guidelines. In both cases, the users are interested in the best possible selection of recommendations that are hard to ignore because of their professional credibility, and in both cases they seek to be as far as possible disburdened of recommendations that are either irrelevant for their goal attainment or are not sufficiently convincing.</p>
         </sec>
         <sec id="en-s4" sec-type="Legal status of recommendations and guidelines">
            <label>4</label>
            <title>Legal status of recommendations and guidelines</title>
            <p>Guidelines are not by definition a rule, because the service user cannot hold the service provider liable for providing them the service according to the procedure laid down in the guidelines. However, insofar as they are professionally credible, it is quite probable that a patient will be able to prove his claim for damages on the basis of a proven violation of the guidelines Likewise, in the case of an action before the social court in the event of a violation of the guidelines, it is quite likely that the patient will be able to prove a violation of public health insurance rights or an impediment of access to the service that the public healthcare system must provide.</p>
            <p>Guidelines are not algorithms or clinical pathways and do not give the practitioner instructions on how to perform the procedure. They are strategic documents that take a stand on the scientific provenance of various ideas or suggestions for action in defined circumstances. The practitioners then themselves decide which of the recommended procedures or which combination thereof they will use. Theoretically, guidelines by definition do not play a decisive role in determining whether a physician has acted unlawfully or not. Patients may themselves study medical literature to find any evidence (e.g. a study, a research, etc.) from which it is possible to prove that in a given case some other method or a different approach would yield a different result. In this respect, guidelines significantly differ from the normative acts – the latter are valid as long as they are adopted by the legislator, irrespective of their scientific or actual persuasiveness, while guidelines are valid only to the extent that there is no other more convincing evidence. But nevertheless, guidelines may have an important role in establishing damage liability in the issues of due diligence (<xref ref-type="bibr" rid="en-b7">7</xref>). One of the key elements of damage liability is a causal link, which determines whether a doctor’s conduct or omission thereof has caused the damage suffered by the patient. It is the guidelines that can best answer this question, as it is easy to derive from them which procedures have already been proposed in certain cases, and what is their scientific persuasiveness. Procedures that are not supported by strong and convincing evidence of their effectiveness, or those that have already been proven ineffective (or. insufficiently differing from placebo), do not fall within the sphere of the physician’s due diligence, as it cannot be proven that their omission has caused the damage. And, of course, vice versa: when physicians performs such a procedure, in the event of side effects, they should be able to prove that the patient has previously been informed of the risks and benefits expected, and that the patient has given their consent.</p>
            <p>There are numerous cases in the German case-law where the courts defined the role of guidelines in that manner (<xref ref-type="bibr" rid="en-b8">8</xref>). The same status is attributed to them by Hurwitz (<xref ref-type="bibr" rid="en-b9">9</xref>).</p>
         </sec>
         <sec id="en-s5"
              sec-type="Are the guidelines a leverage for obtaining public funds?">
            <label>5</label>
            <title>Are the guidelines a leverage for obtaining public funds?</title>
            <p>Properly prepared guidelines should not be a direct leverage for the acquisition of additional public funds, since they give the contractor a considerable autonomy in choosing the recommended procedures and also in terms of their logistical or organizational performance. The price approved by the financier for an individual service is determined by statistical processing of the costs of a large number of providers in relation to a group of comparable treatments that are classified in many countries according to the DRG system (diagnose related groups). The average includes those who achieve goals with cheaper alternatives as well as those achieving them with more expensive ones and those seeking different combinations (i.e. case-mix) (<xref ref-type="bibr" rid="en-b10">10</xref>).</p>
         </sec>
         <sec id="en-s6"
              sec-type="The role of guidelines in epidemiology and the problem of biased guideline interpretation">
            <label>6</label>
            <title>The role of guidelines in epidemiology and the problem of biased guideline interpretation</title>
            <p>When discussing the procedures to be provided by the public healthcare, an epidemiological aspect should always be taken into account, since every service offered by the public healthcare should be made available to every resident in a reasonable time under the same conditions, i.e. at the same phase and stage of their disease. Therefore, in the public health system, “the process” is not only a process that takes place when the patient is seen in the physician’s office, but also all measures which ensure that a person with a certain health problem indeed receives the necessary medical service. In terms of epidemiology, guidelines for resuscitation are not particularly helpful if the logistics does not allow the help to arrive in time. In legal terms, there is no enforceable right of the population to e.g. a high survival rate after myocardial infarction, since the population, being a statistical group, does not have a legal capacity and as such can not file a case against the state or an individual service provider. However, poor logistics increases the risk that a person who has a myocardial infarction will die, an outcome that could be prevented by a timely and adequate intervention. In judicial proceedings, public healthcare service providers generally cannot effectively themselves with the argument of personnel or spatial deficiency. Even at the individual level, physicians can only defend themselves if they prove that in a particular situation they had to triage the patients who sought their help at the same time according to the level of emergency, and that the treatment of a patient had to be postponed because there was another patient at a greater risk. The argument that the order has been determined according to the administrative rule “first come, first served” fails in the court, because the fact that somebody came earlier does not mean that they need the service more urgently. Public service providers and organisers cannot justify their defence by the argument of being overburdened; they are found guilty in every instance of timely service omission (<xref ref-type="bibr" rid="en-b11">11</xref>).</p>
            <p>Public health service providers therefore find themselves in severe legal situation when, on the one hand, they have to provide a certain health service according to the guidelines, but on the other, they are not able to do that, because of a lack of resources. There is an inevitable conflict between the guidelines as a kind of professional axiom that should be beyond any doubt, and the fact that resources available for health service providing are always limited. It is therefore necessary to continuously adapt the processes to the epidemiological situation (i.e. the demand for health services) to new scientific knowledge and to the rational use of available resources (<xref ref-type="bibr" rid="en-b12">12</xref>).</p>
            <p>For example, if the guidelines suggest that in the event of upper respiratory tract infection an antibiotic shall not be given in the first week (<xref ref-type="bibr" rid="en-b13">13</xref>), this statement does not specify that on the first day of infection the physician must recommend to the patient a symptomatic therapy and follow-up its effectiveness on the 8<sup>th</sup> day of treatment. The research has even shown that 50 % of parents who prior to visiting their physician expected that their child would be prescribed an antibiotic are not less satisfied with the service if antibiotic has not been prescribed (<xref ref-type="bibr" rid="en-b14">14</xref>). The guidelines can be implemented in several different ways, among others also by instructing such patients that in the first week of an uncomplicated respiratory infection they need not visit their physician at all. or by ordering the patient to appear for the first check in one week time, when the physician will be able to produce a more comprehensive anamnesis and decide either on the termination of sick leave or its prolongation and introduction of an antibiotic.</p>
            <p>A common mistake in the interpretation of the guidelines stems from the fact that there are many possible approaches to addressing a problem, however, the effectiveness of none of them is evidence-based. In such cases, it is first of all necessary to explain to the patient the nature of their disease and the fact that we do not have an effective therapy for it. This is not a news that the patient wants to hear, but we cannot avoid it by beating around the bush and experimenting.</p>
            <p>The next common mistake occurs in the cases when physicians first make use of an evidence-based procedure, and only when that turns out ineffective, they begin to employ procedures that are not evidence-based. This stems from an intuitive wish to try helping the patient at any price and finding a “miracle medicine”. Although appearing altruistic and pleasing to patients, such an approach in public healthcare is detrimental for its accessibility to patients, who expect of the same physician an evidence-based treatment, but due to the limited resources cannot get it in due time.</p>
            <p>Biased interpretation of guidelines can also be a motive for introducing some informal preventive programmes, which are by definition not evidence-based. For example, if the guidelines claim that the timely diagnosis and excision of a certain type of cancer reduces this disease-related mortality, this does not mean that every inhabitant should be invited once a year to the screening program until there is evidence supporting the belief that systematic checks once a year reduce mortality due to this particular type of cancer. A similar example was the recommendation for the screening program for pregnancy-related diabetes, according to which all pregnant women in Slovenia should be tested (<xref ref-type="bibr" rid="en-b16">16</xref>), although it was known already in 2001 that the effectiveness of such screening programs was not sufficiently clearly demonstrated (<xref ref-type="bibr" rid="en-b17">17</xref>), and in 2006 the World Health Organization developed criteria for assessing the need for such testing in relation to the existing or known risk factors (<xref ref-type="bibr" rid="en-b18">18</xref>).</p>
         </sec>
         <sec id="en-s7"
              sec-type="Conflict of interests and the problem of biased writing of guidelines">
            <label>7</label>
            <title>Conflict of interests and the problem of biased writing of guidelines</title>
            <p>Problems associated with biased writing of guidelines are even more pressing than those associated with their interpretation. Namely, the authors are under constant pressure from both the industry and colleagues to ascribe a higher degree of scientific credibility to certain procedures, in order to use it for underpinning their negotiation position for the acquisition of additional public funds, capacities, personnel and the like. These interests are very short-sighted, as we know that too lenient guidelines create excellent conditions for damages claims against physicians (an unfavourable outcome of the judicial proceedings due to the abandonment of a procedure which is scientifically unconvincing) and for the emergence of catch 22 situations in which physicians – because of the limited resources – can not provide what is expected of them by the guidelines. Too lenient guidelines are therefore mainly in the interest of the industry, researchers and a small group of stakeholders (lobbies), while the service providers, physicians employed by them, healthcare budget and before all patients who are the main beneficiaries of the healthcare system, are their victims.</p>
            <p>Therefore, it is necessary to introduce some safety measures that are adopted from the systemic opinion of the Commission for the Prevention of Corruption, no 06211–9/2012/23 of 3 July 2012 (<xref ref-type="bibr" rid="en-b19">19</xref>):</p>
            <list>
               <list-item>
                  <label>•</label>
                  <p>the obligation to disclose the guidelines’ authors, their employment, income and connections, in particular to the industry, and to assess the possibility of conflict of interests;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>the exclusion of experts from the commissions adopting the guidelines, in the case that the disclosure findings reveal an actual or potential conflict of interests;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>strengthening the responsibility of the drafters of guidelines for achieving public health objectives, including the maintenance of waiting periods within reasonable limits and the reduction of incidence or the consequences of the conditions addressed by the guidelines.</p>
               </list-item>
            </list>
            <p>The conflict of interests is established when a member of the guidelines commission is in legal or economic relation with someone who has their own particular interest as regards the content of the guidelines. The current Integrity and Prevention of Corruption Act provides the following two definitions: “Conflict of interest” means circumstances in which the private interest of an official person influences or appears to influence the impartial and objective performance of their public duties; “Private interest of an official person” means a pecuniary or non-pecuniary benefit which is either to his advantage or to the advantage of his family members or other natural or legal persons with whom he maintains or has maintained personal, business or political relations (<xref ref-type="bibr" rid="en-b20">20</xref>).</p>
            <p>This interest need not necessarily be of financial nature; e.g. a physician who is expecting a more attractive position or a job may have such interest, or a researcher who would obtain a study population or research funds through the implementation of the guidelines, etc. It is important to emphasize that the very fact that someone has received a fee from the industry does not yet prove conflict of interests. It is also important whether the fee is proportionate to the effort involved, how often members of the commission receive it and whether they distributes their part-time work among the different stakeholders, whether they are paid for publishing a specific result, etc. (<xref ref-type="bibr" rid="en-b21">21</xref>).</p>
            <p>The authors of the guidelines should keep in mind that almost any deviation in the guidelines from the evidence-based findings results in material benefit for the operators offering in-the guidelines-permissible procedures, and for their suppliers in the industry,</p>
            <p>Where there is also an intent (i.e. deliberately omitted alternative), the second element is fulfilled (unlawful conduct), which is already a criminal offence. Such practices can and must be prevented by raising awareness and prosecutions, as otherwise the writing of guidelines becomes a convenient tool for overpowering competing healthcare providers and non-transparent implementation of the interests of lobbyist groups.</p>
         </sec>
         <sec id="en-s8"
              sec-type="Strengthening the implementation of guidelines in practice">
            <label>8</label>
            <title>Strengthening the implementation of guidelines in practice</title>
            <sec id="en-s8.1" sec-type="Financing system">
               <label>8.1</label>
               <title>Financing system</title>
               <p>Even with the established system of guidelines, physicians shall maintain autonomy in choosing the type of diagnosis or treatment they offer to the patient. For the sake of legal certainty, it is advisable that physicians decide for one of the methods recommended by the guidelines, but nevertheless, they may also choose another one, if it may be reasonably expected that the patient will not be harmed by it and that in the case of an action for damages they can prove that sufficient attention was paid to the patient’s safety.</p>
               <p>The question that raises greater concern is who bears the costs if a physician chooses a more expensive alternative. In any case, this should not be a health insurance company that should pay the same price regardless of the method chosen. But, among the operators, their practices differ. Some will let physicians make their own decisions as long as these are rational and more expensive methods are chosen only exceptionally. Where this turns out insufficient, the operators implement stricter rules and require that physicians obtain consent from the multidisciplinary team or the expert management of the institution prior to choosing a more expensive method.</p>
               <p>Of course, the patient should always be informed about all the methods available by the guidelines, and they should be free to choose any of them. However, the patient’s choice may not influence the operator’s costs. If a patient selects a more expensive method, although the healthcare operator considers that the cheaper method is sufficient, the patient should be treated as a private patient (the choice of a service that is considered unnecessary by an authorised physician – item 7 of Article 25 of the Compulsory Health Insurance Rules), of course, provided that the patient consents to being treated as a private patient (<xref ref-type="bibr" rid="en-b22">22</xref>,<xref ref-type="bibr" rid="en-b23">23</xref>).</p>
            </sec>
            <sec id="en-s8.2"
                 sec-type="Clinical pathways and their link to the guidelines">
               <label>8.2</label>
               <title>Clinical pathways and their link to the guidelines</title>
               <p>Clinical pathway is a flow chart of procedures and decisions used by the operator in dealing with a particular clinical problem. Guidelines most easily and completely find their way into practice through clinical pathways. In terms of structure, clinical pathway is a protocol describing in more detail the implementation of guidelines in a local environment according to the existing conditions. As a standardised multidisciplinary care plan it identifies the sequence of clinical measures, timeframes, milestones and expected results of a homogeneous group of patients. Guidelines generally cover several clinical problems, wile clinical pathways are more focused on a particular problem or its part. Therefore, individual guidelines are generally associated with several clinical pathways. (<xref ref-type="bibr" rid="en-b24">24</xref>).</p>
               <p>Compared to guidelines, a clinical pathway is much more defined, as it also includes steps that the guidelines do not specify. Clinical pathways ensure that the patient is treated by the right experts, in the right order, in the right place, at the right time, with appropriate means, with the correct outcome of the treatment and in accordance with the needs and expectations of the patient (<xref ref-type="bibr" rid="en-b25">25</xref>).</p>
               <p>Sometimes the operators also expect the authors of the guidelines to provide answers to the questions how to implement the guideline in the organizational or financial sense. They often do this by creating a conflict of interest, i.e., by using their position as an employer to make a member of the commission, otherwise employed by the contractor, reach the adaptation of the guideline to the clinical pathway of an individual operator. All these practices are corrupt and members who are exposed to such pressures should be excluded from the committees. The guidelines may only include evidence-based knowledge, irrespective of whether or not this evidence supports the practice or organization of a particular operator and its budget. The guidelines shall not include anything that we find sensible or logical but is not evidence-based. A guideline always allows for more possibilities of implementation, and the search for these options is a matter for the operators and not the authors of the guidelines. This can not be easily introduced in the Slovenian context, since we use to adapt the solutions and even the public health objectives to the given organization and financing models rather than being the opposite.</p>
               <p>In Slovenia, there is also a persistent practice of prescribing business processes of leading operators, or even processes as have been implemented by the leading operator (generally the UMC Ljubljana). Even to the extent that they sometimes want to use them as a guideline. This, of course is not an evidence-based clinical practice, as such a finding would require a study with strong evidence that the clinical pathway of such operator is statistically significantly more effective than the average practices of healthcare institutions worldwide.</p>
            </sec>
            <sec id="en-s8.3" sec-type="Standards and their link to the guidelines">
               <label>8.3</label>
               <title>Standards and their link to the guidelines</title>
               <p>By definition (SIST EN 45020), a standard is a document generated by consensus and approved by a recognised authority, which sets out the rules, guidelines or characteristics of the activities and their results (<xref ref-type="bibr" rid="en-b26">26</xref>). Standards are similar to the guidelines in that they contain a simple statement that covers a particular situation. However, they differ from the guidelines in that they have in addition to the recommendatory also a prescriptive part which specifies:</p>
               <list>
                  <list-item>
                     <label>•</label>
                     <p>what needs to be done in a particular situation;</p>
                  </list-item>
                  <list-item>
                     <label>•</label>
                     <p>sometimes also who is responsible for doing that;</p>
                  </list-item>
                  <list-item>
                     <label>•</label>
                     <p>what are the expected results or indicators.</p>
                  </list-item>
               </list>
               <p>Standards are essentially a kind of draft regulation. They are composed in such a way that they can be used as a regulation, but they get their binding nature only when they are introduced with a certain regulation, a general act of an organization or a contract, i.e. with a legally binding document. The essential difference between the standard and the guideline is in that the operators use standard either because they have committed themselves to it (e.g. by a contract, a bid, a binding statement, etc.) or because a certain authority prescribed them to respect it by means of a regulation, a general act of the organization, etc., while the operator uses the guideline because it is difficult to ignore due to its professional conviction.</p>
               <p>However, standards differ from a standard regulation in that they also have recommendatory part on the basis of which they are adopted. While a regulation is exclusively a matter of the will of those who adopt it and does not require any objective justification for its validity, standards must be based on guidelines, i.e. on a professional consensus. We could say that standards are regulations that were developed on the basis of the knowledge of the profession. The fact that the operator has acted according to the standard does not of itself exclude liability for damages, but the latter is excluded under the same assumptions as in the guidelines, i.e. when there is no convincing evidence that a different (non-standard) approach would prevent the harmful effect.</p>
               <p>The role of standards is primarily in that it is possible to compare two different products of two different services with each other. Standards do not constitute an exhaustive description that would not allow the user of the standard to have any autonomy as regards the method of implementation. They only define a minimum set of characteristics for which there is a consensus of the profession that they are necessary in order for a service or a product to be what the operator claims it to be.</p>
               <p>In the context of public healthcare, the adoption of standards is necessary in particular in two cases:</p>
               <list>
                  <list-item>
                     <label>•</label>
                     <p>when the operator or the public healthcare system intends to provide the patient with a specific procedure and it needs to be assessed whether or not the patient has received it;</p>
                  </list-item>
                  <list-item>
                     <label>•</label>
                     <p>when a procedure is divided among several operators or institutions and the next holder cannot take over the procedure before its previous phase has been completed in accordance with the standard.</p>
                  </list-item>
               </list>
            </sec>
         </sec>
         <sec id="en-s9" sec-type="Transfer of foreign guidelines">
            <label>9</label>
            <title>Transfer of foreign guidelines</title>
            <p>Science is universal and convincing in itself, and its findings reach beyond national or political borders. Therefore, we often follow the principle that guidelines need not be created in each country separately, and that nothing can really go wrong if we copy the guidelines that have already been prepared by someone else.</p>
            <p>However, we have to distinguish between the following two levels:</p>
            <list>
               <list-item>
                  <label>•</label>
                  <p>large-scale multicentric studies, which serve as a basis for foreign guidelines the credibility of which is difficult to contest;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>the authorities which adopt a particular recommendation.</p>
               </list-item>
            </list>
            <p>In the Slovenian legal setting, foreign guidelines and recommendations have the status of a good review article. This means that they can be one of the sources from which Slovenian recommendations are drawn up, and also a guide that can be used by Slovenian practitioners in the absence of Slovenian recommendations; but they should not be the only source. The Slovenian authorities that adopt guidelines must review all the world’s credible literature, including the recommendations and guidelines from foreign countries, and use that to draw up their own recommendation as an independent work. The results of Slovenian studies should be reviewed and included in the recommendations when they are not statistically significantly different from those from world literature. However, if they statistically significantly differ, an appropriate position should be taken, and it should be determined whether the differences are attributable to a smaller sample of the Slovenian study or a greater specificity of the Slovenian population. We can speak of specificity only when a study carried out on a Slovenian population sample is at least approximately equivalent to foreign reference studies in terms of their methodology and sample size. When the Slovenian studies statistically significantly differ from foreign ones on a small sample, they should not affect the content of national recommendations, since the difference is more likely to be due to the sampling or methodological error than the biological differences between the inhabitants of Slovenia and other Europeans or Earth people in general.</p>
            <p>It is also necessary to mention various European guidelines. These can be used directly in cross-border projects, e.g. in making decisions on project funding by the EU institutions. Furthermore, European guidelines could also be directly used in the case of cross-border healthcare services, e.g. when an operator from one state attracts patients in the territory of another state. However, in the Slovenian national system (e.g. in decisions on financing by the Slovenian state or HIIS) they have – likewise all other foreign recommendations – only the status of a good review article, and in drawing up the Slovenian national guidelines they have to be assessed within the context of other available sources.</p>
            <p>It is very important to consider whether it is reasonable for Slovenia to have its own system of guidelines, given the fact that, according to the documentary sources that underlie them, it is difficult to expect that they will differ significantly from those from other countries. On the other hand, the question is whether this can be avoided at all, if we do not want to have a situation when e.g. someone will follow Spanish, the other Canadian and the third one Australian guidelines. This problem is generally solved by the internalisation of foreign or international guidelines in such a way that the authority responsible for adopting the Slovenian guidelines adopts the international guideline and at the same time implements it as a national one. However, there are some prerequisites:</p>
            <list>
               <list-item>
                  <label>•</label>
                  <p>the guidelines must meet all standards that the Slovenian clinical or national guidelines would fulfil;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>- an international recommendation should be accompanied by a statement from the Slovenian authority that an international recommendation should also be considered as a Slovenian national recommendation;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>internalised recommendations should be consistent with, or at least should not be contradictory to the results of the Slovenian expert literature, which should be thoroughly reviewed before adopting the foreign guidelines.</p>
               </list-item>
            </list>
            <p>This is a fairly practical approach, since in this case there are no differences between the standards on the domestic and cross-border markets.</p>
         </sec>
         <sec id="en-s10"
              sec-type="Competent Authorities for the adoption of guidelines in Slovenia">
            <label>10</label>
            <title>Competent Authorities for the adoption of guidelines in Slovenia</title>
            <p>Health Services Act (ZZDej) does not include terms »guidelines« or »recommendations«, therefore the competences for drawing up guidelines should be derived mutatis mutandis from Article 74 of the ZZDej. In accordance with this, the General Expert Collegiums (hereinafter: RSK) shall establish professional doctrine with respect to health enhancement, prevention, identification, treatment, the nursing and rehabilitation of people taken ill or injured and persons with mental and physical development disorders. According to the ZZDej, the RSK is the highest expert body in a particular area, which coordinates proposals of university hospitals, professional associations and chambers, higher education institutions, health institutions and individual experts. Based on this definition we would conclude that the documents drawn up by the RSK have the status of recommendation until confirmed by the Health Council.</p>
            <p>Pursuant to the first paragraph of Article 75 of the ZZDej, the Health Council is competent for the transition of recommendations into guidelines. According to this provision, the professional proposals of the RSK affecting the content and scope of health care, and thus health policy and healthcare financing, are dealt with and endorsed by the Health Council as the highest professional coordinating body in the field of health care. The Health Council shall design the content of health programmes in terms of their feasibility, the uniform development of all disciplines and the principle of equal accessibility. It may require the General Expert Collegiums to adapt professional doctrine to economic capacities of the country or to propose the implementation of the programmes according to priorities and to a limited extent.The Health Council is established at the ministry responsible for health, and consists of health care representatives, councillors, senior councillors, faculty teachers and other renowned experts in the field of health care, health economics and healthcare organisations. (<xref ref-type="bibr" rid="en-b27">27</xref>).</p>
            <p>The Slovenian Medical Association has prepared a draft pathway for the adoption of professional recommendations, clinical guidelines and national guidelines, which was also approved by the Health Council on 7 March 2013 (<xref ref-type="bibr" rid="en-b28">28</xref>). <italic toggle="yes">Clinical guidelines and recommendations</italic> shall be prepared by working groups within the framework of professional associations, societies and sections, which are organised in the association of medical societies – the Slovenian Medical Association (hereinafter: SZD). The prepared text is confirmed at a meeting of associations, societies or sections. Afterwards, a recommendation or a clinical guideline shall be submitted to the expert council for a particular area, which will forward their harmonised and finalised version for consideration to the General Expert Council of the SZD. When the text has been confirmed by the latter, it may be published in <italic toggle="yes">Zdravniški</italic>
               <italic toggle="yes"> vestnik</italic>.</p>
            <p>A draft national guideline is first reviewed and endorsed by the RSK for a particular area, and then sent to the Health Council for consideration and approval. Prior to discussion, a working group for the guideline shall be constituted to prepare an economic assessment of resources, and the Health Council may request the applicant to amend their proposal as necessary.</p>
            <p>Because the national guidelines - unlike clinical guidelines and recommendations - do not only express the consensus of the profession but respond to a question of a decision-maker who is interested in the legal or financial aspects of dealing with a particular medical issue, we need an authority in Slovenia, which would also take into account these aspects, as professional councils and their members are not responsible for healthcare financing. It is questionable, however, whether the Health Council is the best solution because, due to its affiliation to the Ministry of Health, it does not provide a sufficient guarantee of independence and impartiality since its members are appointed by the Minister with the consent of the Government. Furthermore, pursuant to the first paragraph of Article 7 of the Rules concerning the Health Council, the term of office of its members is linked with the term of office of the Minister of Health. It would be more appropriate for the guidelines to be adopted by independent institutions, e.g. an independent public agency or an institute for healthcare quality. Although the British NICE (National Institute for Health and Care Excellence) is also responsible for its work to the Ministry of Health, it is autonomous in operational respect (<xref ref-type="bibr" rid="en-b30">30</xref>). In the USA, guidelines are adopted by the Agency for Healthcare and Quality (AHRO), which functions as an independent body within the Ministry of Health (<xref ref-type="bibr" rid="en-b31">31</xref>). In Germany, guidelines are adopted by a kind of independent mixed commission (<italic toggle="yes">Gemeinsamer</italic>
               <italic toggle="yes"> Bundesauschuss</italic>), which – in line with the tradition of the German healthcare system - consists of healthcare stakeholders, i.e. healthcare insurance companies and healthcare service providers (<xref ref-type="bibr" rid="en-b32">32</xref>). A similar body called Haute Autorité de Santé (HAS) also exists in France; this body too is composed of stakeholders in health sector, and financed by French public healthcare funders, i.e. the state and insurance companies (<xref ref-type="bibr" rid="en-b33">33</xref>).</p>
         </sec>
      </body>
      <back>
         <ref-list>
            <ref id="en-b1">
               <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>US Preventive Services Task Force</collab>
                    </person-group>. 
                    <source>GRADE definitions</source>. 
                    <year>2016</year>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>]. 
                    <comment>Available from:<uri>https://www.uspreventiveservicestaskforce.org/Page/Name/grade-definitions</uri>
                  </comment>.
                </mixed-citation>
            </ref>
            <ref id="en-b2">
               <mixed-citation publication-type="webpage">
                    <person-group>
                     <name name-style="western">
                        <surname/>
                     </name>
                  </person-group>.
                    <source>Levels of Evidence. Centre for Evidence Based Medicine</source>.
                    <year>2016</year>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/</uri>
                  </comment>.
                </mixed-citation>
            </ref>
            <ref id="en-b3">
               <mixed-citation publication-type="webpage">
                    <person-group>
                     <name name-style="western">
                        <surname/>
                     </name>
                  </person-group>.
                    <source>BMJ clinical evidence</source>. 
                    <year>2016</year> 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>http://clinicalevidence.bmj.com/x/set/static/ebm/learn/665072.html</uri>
                  </comment>.
                </mixed-citation>
            </ref>
            <ref id="en-b4">
               <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <name name-style="western">
                        <surname>Aaron</surname>
                        <given-names>M</given-names>
                     </name>, 
                        <name name-style="western">
                        <surname>Harris</surname>
                        <given-names>MP</given-names>
                     </name>,
                        <name name-style="western">
                        <surname>Lauri</surname>
                        <given-names>AH</given-names>
                     </name>, 
                        <name name-style="western">
                        <surname>Qaseem </surname>
                        <given-names>A</given-names>
                     </name>; 
                        <collab>High Value Care Task Force of the American College of Physicians and for the Centers for Disease Control and Prevention</collab>.
                    </person-group>. 
                    <article-title>Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults</article-title>.
                    <source>Ann Intern Med</source>.
                    <year>2016</year>;
                    <volume>164</volume>(
                    <issue>6</issue>):
                    <fpage>415</fpage>–
                    <lpage>34</lpage>. 
                    <pub-id pub-id-type="doi">10.7326/M15-1840</pub-id>
                    <pub-id pub-id-type="pmid">    26785402</pub-id>
                    <issn>0003-4819</issn>
                </mixed-citation>
            </ref>
            <ref id="en-b5">
               <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>American Academy of Pediatrics</collab>
                    </person-group>. Standards, Recommendations, Guidelines, and Regulations.  
                    <year>2016</year>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>www.healthychildcare.org/StandardsRegulations.html</uri>
                  </comment>.
                </mixed-citation>
            </ref>
            <ref id="en-b6">
               <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>World Health Organization</collab>
                    </person-group>. 
                    <article-title>WHO guidelines approved by the Guidelines Review Committee</article-title>. 
                    <year>2016</year>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>http://www.who.int/publications/guidelines/en/</uri>
                  </comment>.
                </mixed-citation>
            </ref>
            <ref id="en-b7">
               <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                        <surname>Schwartz</surname>
                        <given-names>PJ</given-names>
                     </name>, 
                        <name name-style="western">
                        <surname>Breithardt</surname>
                        <given-names>G</given-names>
                     </name>, 
                        <name name-style="western">
                        <surname>Howard</surname>
                        <given-names>AJ</given-names>
                     </name>, 
                        <name name-style="western">
                        <surname>Julian</surname>
                        <given-names>DG</given-names>
                     </name>, 
                        <name name-style="western">
                        <surname>Rehnqvist Ahlberg</surname>
                        <given-names>N</given-names>
                     </name>
                    </person-group>. 
                    <article-title>The legal implications of medical guidelines - Task Force of the European Society of Cardiology</article-title>. 
                    <source>Eur Heart J</source>. 
                    <year>1999</year>
                    <month>Aug</month>;
                    <volume>20</volume>(
                    <issue>16</issue>):
                    <fpage>1152</fpage>–
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.1053/euhj.1999.1677</pub-id>
                    <pub-id pub-id-type="pmid">10448023</pub-id>
                    <issn>0195-668X</issn>
                </mixed-citation>
            </ref>
            <ref id="en-b8">
               <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <name name-style="western">
                        <surname>Grams</surname>
                        <given-names>HA</given-names>
                     </name>,
                    </person-group>. 
                    <source>Leitlinien: Begriff, Entwicklung, Bedeutung für die Aufklärung und die ärztliche Handlungsfreiheit</source>.
                    <year>2016</year>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>https://berliner-anwaltsverein.de/files/media/download/Arbeitsgruppe%20Medizinrecht%20Archiv/AGMED_2012_Leitlinien-2012.pdf</uri>
                  </comment>.
                </mixed-citation>
            </ref>
            <ref id="en-b9">
               <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                        <surname>Hurwitz</surname>
                        <given-names>B</given-names>
                     </name>
                    </person-group>. 
                    <article-title>Guidelines and jurisprudence: advice, guidance or regulation?</article-title> 
                    <source>Epidemiol Prev</source>. 
                    <year>1998</year>
                    <month>Apr-Jun</month>;
                    <volume>22</volume>(
                    <issue>2</issue>):
                    <fpage>85</fpage>–
                    <lpage>93</lpage>.
                    <pub-id pub-id-type="pmid">9789380</pub-id>
                    <issn>1120-9763</issn>
                </mixed-citation>
            </ref>
            <ref id="en-b10">
               <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>German hospital service</collab>
                    </person-group>. 
                    <article-title>DRG tables</article-title>.
                    <year>2017</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>http://www.drg.german-hospital-service.com/</uri>
                  </comment>.
                </mixed-citation>
            </ref>
            <ref id="en-b11">
               <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <name name-style="western">
                        <surname>Bitterman</surname>
                        <given-names>RA</given-names>
                     </name>; 
                        <collab>Overcrowded Emergency Department Leads to Lawsuit Over EMTALA</collab>
                    </person-group>. 
                    <article-title>AHC Media</article-title>.
                    <year>2016</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>https://www.ahcmedia.com/articles/16249-overcrowded-emergency-department-leads-to-lawsuit-over-emtala</uri>
                  </comment>.
                </mixed-citation>
            </ref>
            <ref id="en-b12">
               <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                        <surname>Saarni</surname>
                        <given-names>SI</given-names>
                     </name>, 
                        <name name-style="western">
                        <surname>Gylling</surname>
                        <given-names>HA</given-names>
                     </name>
                    </person-group>. 
                    <article-title>Evidence based medicine guidelines: a solution to rationing or politics disguised as science?</article-title>
                    <source>J Med Ethics</source>. 
                    <year>2004</year>
                    <month>Apr</month>;
                    <volume>30</volume>(
                    <issue>2</issue>):
                    <fpage>171</fpage>–
                    <lpage>5</lpage>. 
                    <pub-id pub-id-type="doi">10.1136/jme.2003.003145</pub-id>
                    <pub-id pub-id-type="pmid">15082812</pub-id>
                    <issn>0306-6800</issn>
                </mixed-citation>
            </ref>
            <ref id="en-b13">
               <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                        <surname>Wong</surname>
                        <given-names>DM</given-names>
                     </name>, 
                        <name name-style="western">
                        <surname>Blumberg</surname>
                        <given-names>DA</given-names>
                     </name>, 
                        <name name-style="western">
                        <surname>Lowe</surname>
                        <given-names>LG</given-names>
                     </name>
                    </person-group>. 
                    <article-title>Guidelines for the Use of Antibiotics in Acute Upper Respiratory Tract Infections</article-title>.
                    <source>Am Fam Physician</source>. 
                    <year>2006</year>
                    <month>Sep</month>;
                    <volume>74</volume>(
                    <issue>6</issue>):
                    <fpage>956</fpage>–
                    <lpage>66</lpage>.
                    <pub-id pub-id-type="pmid">17002029</pub-id>
                    <issn>0002-838X</issn>
                </mixed-citation>
            </ref>
            <ref id="en-b14">
               <mixed-citation publication-type="journal">
                        <person-group person-group-type="author">
                            <name name-style="western">
                        <surname>Wong</surname>
                        <given-names>DM</given-names>
                     </name>, 
                            <name name-style="western">
                        <surname>Blumberg</surname>
                        <given-names>DA</given-names>
                     </name>, 
                            <name name-style="western">
                        <surname>Lowe</surname>
                        <given-names>LG</given-names>
                     </name>
                        </person-group>. 
                        <article-title>Guidelines for the Use of Antibiotics in Acute Upper Respiratory Tract Infections</article-title>.
                        <source>Am Fam Physician</source>. 
                        <year>2006</year>
                        <month>Sep</month>;
                        <volume>74</volume>(
                        <issue>6</issue>):
                        <fpage>956</fpage>–
                        <lpage>66</lpage>.
                        <pub-id pub-id-type="pmid">17002029</pub-id>
                        <issn>0002-838X</issn>
                    </mixed-citation>
            </ref>
            <ref id="en-b15">
               <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                        <surname>Elgizouli</surname>
                        <given-names>MA</given-names>
                     </name>
                    </person-group>. 
                    <article-title>What’s a good doctor and how do you make one? Medical profession needs input from belief in humanity and ethics</article-title>. 
                    <source>BMJ</source>. 
                    <year>2002</year>
                    <month>Sep</month>;
                    <volume>325</volume>(
                    <issue>7366</issue>):
                    <fpage>711</fpage>. 
                    <pub-id pub-id-type="doi">10.1136/bmj.325.7366.711</pub-id>
                    <pub-id pub-id-type="pmid">12358023</pub-id>
                    <issn>0959-8138</issn>
                </mixed-citation>
            </ref>
            <ref id="en-b16">
               <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                        <surname>Krajnc</surname>
                        <given-names>M</given-names>
                     </name>, 
                        <name name-style="western">
                        <surname>Zavratnik</surname>
                        <given-names>A</given-names>
                     </name>, 
                        <name name-style="western">
                        <surname>Čokolič</surname>
                        <given-names>M</given-names>
                     </name>
                    </person-group>. 
                    <article-title>Nosečnostna sladkorna bolezen</article-title>. 
                    <source>Medicinski mesečnik</source>
                    <year>2008</year>;
                    <volume>4</volume>:
                    <fpage>30</fpage>–
                    <lpage>6</lpage>.
                </mixed-citation>
            </ref>
            <ref id="en-b17">
               <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                        <surname>Virjee</surname>
                        <given-names>S</given-names>
                     </name>, 
                        <name name-style="western">
                        <surname>Robinson</surname>
                        <given-names>S</given-names>
                     </name>, 
                        <name name-style="western">
                        <surname>Johnston</surname>
                        <given-names>D G</given-names>
                     </name>
                    </person-group>. 
                    <article-title>Screening for diabetes in pregnancy</article-title>. 
                    <source>J R Soc Med</source>. 
                    <year>2001</year>
                    <month>Oct</month>;
                    <volume>94</volume>(
                    <issue>10</issue>):
                    <fpage>502</fpage>–
                    <lpage>9</lpage>.
                    <pub-id pub-id-type="doi">10.1177/014107680109401003</pub-id>
                    <pub-id pub-id-type="pmid">11581342</pub-id>
                    <issn>0141-0768</issn>
                </mixed-citation>
            </ref>
            <ref id="en-b18">
               <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>World Health Organization</collab>
                    </person-group>. 
                    <article-title>Diagnostic Criteria and Classification of Hyperglykaemia First Detected in Pregnancy</article-title>.
                    <year>2017</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>http://apps.who.int/iris/bitstream/10665/85975/1/WHO_NMH_MND_13.2_eng.pdf?ua=1</uri>
                  </comment>.
                </mixed-citation>
            </ref>
            <ref id="en-b19">
               <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <name name-style="western">
                        <surname>Klemenčič</surname>
                        <given-names>G</given-names>
                     </name>
                    </person-group>. 
                    <article-title>Sistemsko načelno mnenje glede krepitve in omejevanja nasprotja interesov pri delovanju različnih komisij, svetov in delovnih skupin, v katerih sodelujejo posamezniki, ki niso zaposleni v javnem sektorju</article-title>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>https://www.kpk-rs.si/upload/datoteke/dopolnjeno%20sistemsko%20na%C4%8Delno%20mnenje%20183.pdf</uri>
                  </comment>.
                </mixed-citation>
            </ref>
            <ref id="en-b20">
               <mixed-citation publication-type="journal">
                    <person-group>
                     <name name-style="western">
                        <surname/>
                     </name>
                  </person-group>.
                    <article-title>Zakon o integriteti in preprečevanju korupcije</article-title>.
                    <source>Ur l RS</source>. 
                    <year>2011</year>(
                    <issue>69</issue>) 
                </mixed-citation>
            </ref>
            <ref id="en-b21">
               <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>National Institute for Health and Care Excellence</collab>
                    </person-group>. Policy on Conflicts of Interest.
                    <year>2017</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>https://www.nice.org.uk/Media/Default/Get-involved/Fellows%20and%20scholars%20unsecure/Conflicts-of-interest-policy.pdf</uri>
                  </comment>.
                </mixed-citation>
            </ref>
            <ref id="en-b22">
               <mixed-citation publication-type="journal">
                  <person-group>
                     <name name-style="western">
                        <surname/>
                     </name>
                  </person-group>.
                <article-title>Pravila obveznega zdravstvenega zavarovanja</article-title>.
                <source>Ur l RS</source>. 
                <year>1994</year>(
                <issue>69</issue>),  
                <year>1996</year>(
                <issue>39</issue>),  
                <year>1996</year>(
                <issue>70</issue>),  
                <year>1997</year>(
                <issue>47</issue>),  
                <year>1998</year>(
                <issue>3</issue>),  
                <year>1998</year>(
                <issue>51</issue>), 
                <year>1998</year>(
                <issue>73</issue>), 
                <year>1999</year>(
                <issue>6</issue>),
                <year>2000</year>(
                <issue>61</issue>),
                <year>2000</year>(
                <issue>64</issue>),
                <year>2002</year>(
                <issue>59</issue>),
                <year>2003</year>(
                <issue>18</issue>),
                <year>2003</year>(
                <issue>30</issue>),
                <year>2003</year>(
                <issue>35</issue>),
                <year>2003</year>(
                <issue>78</issue>),
                <year>2004</year>(
                <issue>84</issue>),
                <year>2005</year>(
                <issue>44</issue>),
                <year>2006</year>(
                <issue>86</issue>),
                <year>2006</year>(
                <issue>90</issue>),
                <year>2007</year>(
                <issue>64</issue>),
                <year>2008</year>(
                <issue>33</issue>),
                <year>2009</year>(
                <issue>7</issue>).
                </mixed-citation>
            </ref>
            <ref id="en-b23">
               <mixed-citation publication-type="journal">
                    <person-group>
                     <name name-style="western">
                        <surname/>
                     </name>
                  </person-group>.
                    <article-title>Zakon o pacientovih pravicah</article-title>.
                    <source>Ur l RS</source>. 
                    <year>2008</year>(
                    <issue>15</issue>).
                </mixed-citation>
            </ref>
            <ref id="en-b24">
               <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                        <surname>Geršak</surname>
                        <given-names>K</given-names>
                     </name>, 
                        <name name-style="western">
                        <surname>Fras</surname>
                        <given-names>Z</given-names>
                     </name>, 
                        <name name-style="western">
                        <surname>Rems</surname>
                        <given-names>M</given-names>
                     </name>
                    </person-group>. 
                    <article-title>Ali vemo, kakšne morajo biti dobre klinične smernice?</article-title>
                    <source>Zdrav Vestn</source>. 
                    <year>2016</year>;
                    <volume>85</volume>:(
                    <issue>1</issue>)
                    <fpage>6</fpage>–
                    <lpage>14</lpage>.
                    <issn>0350-0063</issn>
                </mixed-citation>
            </ref>
            <ref id="en-b25">
               <mixed-citation publication-type="book">
                    <person-group person-group-type="author">
                        <name name-style="western">
                        <surname>Marušič</surname>
                        <given-names>B</given-names>
                     </name>, 
                        <name name-style="western">
                        <surname>Simčič</surname>
                        <given-names>B</given-names>
                     </name>
                    </person-group>. 
                    <source>Priročnik za oblikovanje kliničnih poti</source>.
                    <publisher-loc>Ljubljana</publisher-loc>:
                    <publisher-name>Ministrstvo za zdravje</publisher-name>;
                    <year>2009</year>. pp.
                    <fpage>6</fpage>–
                    <lpage>7</lpage>.
                    <isbn>978–961–6523–38–7</isbn>
                </mixed-citation>
            </ref>
            <ref id="en-b26">
               <mixed-citation publication-type="webpage">
                    <person-group>
                     <name name-style="western">
                        <surname/>
                     </name>
                  </person-group>.
                    <source>Izvozno okno</source>. 
                    <year>2017</year>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2019-11-27">cited 2019 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>http://www.izvoznookno.si/Dokumenti/Mednarodno_trgovanje/Standardi_in_standardizacija_8426.aspx</uri>
                  </comment>.
                </mixed-citation>
            </ref>
            <ref id="en-b27">
               <mixed-citation publication-type="journal">
                        <person-group>
                     <name name-style="western">
                        <surname/>
                     </name>
                  </person-group>.
                <article-title>Zakon o zdravstveni dejavnosti</article-title>.
                        <source>Ur l RS</source>. 
                        <year>2005</year>(
                        <issue>23</issue>),  
                        <year>2008</year>(
                        <issue>15</issue>),  
                        <year>2008</year>(
                        <issue>77</issue>),  
                        <year>2012</year>(
                        <issue>40</issue>),  
                        <year>2013</year>(
                        <issue>14</issue>),  
                        <year>2016</year>(
                        <issue>88</issue>), 
                        <year>2017</year>(
                        <issue>64</issue>).
                    </mixed-citation>
            </ref>
            <ref id="en-b28">
               <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>Ministrstvo za zdravje, Zdravstveni svet</collab>.
                    </person-group>.   
                        <source>Zapisnik seje Zdravstvenega sveta 1</source>.
                    <year>2018</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2019-11-27">cited 2019 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>http://www.mz.gov.si/fileadmin/mz.gov.si/pageuploads/zdravstveni_svet/ZS_18/zapisniki_2018/zapisnik_1-18-ZS.pdf</uri>
                  </comment>.
                </mixed-citation>
            </ref>
            <ref id="en-b29">
               <mixed-citation publication-type="journal">
                    <person-group>
                     <name name-style="western">
                        <surname/>
                     </name>
                  </person-group>.
                    <article-title>Pravilnik o Zdravstvenem svetu</article-title>.
                    <source>Ur l RS</source>. 
                    <year>1988</year>(
                    <issue>1</issue>),  
                    <year>2006</year>(
                    <issue>40</issue>),  
                    <year>2009</year>(
                    <issue>8</issue>),  
                    <year>2011</year>(
                    <issue>11</issue>),  
                    <year>2012</year>(
                    <issue>48</issue>)
                </mixed-citation>
            </ref>
            <ref id="en-b30">
               <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>National Institute for Health and Care Excellence</collab>
                    </person-group>. 
                    <source>Who we are</source>. 
                    <year>2017</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>https://www.nice.org.uk/about/who-we-are</uri>
                  </comment>.
                </mixed-citation>
            </ref>
            <ref id="en-b31">
               <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>Agency for Healthcare Research and Quality</collab>
                    </person-group>. 
                    <source>About AHRQ</source>. 
                    <year>2017</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>https://www.ahrq.gov/cpi/about/index.html</uri>
                  </comment>.
                </mixed-citation>
            </ref>
            <ref id="en-b32">
               <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>Gemeinsamer Bundesausschuss</collab>
                    </person-group>. 
                    <source>Der Gemeinsame Bundesausschuss stellt sich vor</source>. 
                    <year>2017</year>.  
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>https://www.g-ba.de/institution/struktur/</uri>
                  </comment>.
                </mixed-citation>
            </ref>
            <ref id="en-b33">
               <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>Haute Autorité de Santé</collab>
                    </person-group>. 
                    <source>Organisation de la HAS</source>. 
                    <year>2017</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2017-11-27">cited 2017 Nov 27</date-in-citation>].
                    <comment>Available from:<uri>http://www.has-sante.fr/portail/jcms/c_412227/fr/organisation-de-la-has</uri>
                  </comment>.
                </mixed-citation>
            </ref>
         </ref-list>
      </back>
   </sub-article>
</article>
